Unity Bancorp (UNTY) 10-Q 8 Nov 23 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2023	Oct. 31, 2023
Document and Entity Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	1-12431
Entity Registrant Name	Unity Bancorp, Inc.
Entity Incorporation, State or Country Code	NJ
Entity Tax Identification Number	22-3282551
Entity Address, Address Line One	64 Old Highway 22
Entity Address, City or Town	Clinton
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	08809
City Area Code	800
Local Phone Number	618-2265
Title of 12(b) Security	Common stock
Trading Symbol	UNTY
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		10,057,712
Entity Central Index Key	0000920427
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
ASSETS
Cash and due from banks	$ 26,224	$ 19,699
Interest-bearing deposits	135,223	95,094
Cash and cash equivalents	161,447	114,793
Securities:
Debt securities available for sale, at market value	92,122
Debt securities available for sale, at market value		95,393
Debt securities held to maturity, at amortized cost	35,956
Debt securities held to maturity, at amortized cost		35,760
Equity securities, at market value	8,013	9,793
Total securities	136,091	140,946
Loans:
Total loans	2,173,190
Allowance for credit losses	(25,918)
Net loans	2,147,272
Loans:
Total loans		2,106,559
Allowance for credit losses		(25,196)
Net loans		2,081,363
Premises and equipment, net	19,783	20,002
Bank owned life insurance ("BOLI")	25,223	26,776
Deferred tax assets, net	13,249	12,345
Federal Home Loan Bank ("FHLB") stock	19,882	19,064
Accrued interest receivable	16,101	13,403
Goodwill	1,516	1,516
Prepaid expenses and other assets	22,442	14,740
Total assets	2,563,006	2,444,948
Deposits:
Noninterest-bearing demand	425,436	494,184
Interest-bearing demand	297,705	276,218
Savings	548,325	591,826
Brokered time deposits	197,636	189,644
Time deposits	415,808	235,656
Total deposits	1,884,910	1,787,528
Borrowed funds	388,610	383,000
Subordinated debentures	10,310	10,310
Accrued interest payable	1,412	691
Accrued expenses and other liabilities	25,380	24,192
Total liabilities	2,310,622	2,205,721
Shareholders' equity:
Common stock	99,741	97,204
Retained earnings	182,557	156,958
Treasury stock	(25,954)	(11,675)
Accumulated other comprehensive loss	(3,960)	(3,260)
Total shareholders' equity	252,384	239,227
Total liabilities and shareholders' equity	2,563,006	2,444,948
SBA loans held for sale
Loans:
Total loans	19,387
Loans:
Total loans		27,928
SBA loans held for investment
Loans:
Total loans	40,873
Allowance for credit losses	(1,656)
Loans:
Total loans		38,468
Allowance for credit losses		(875)
SBA PPP loans
Loans:
Total loans	2,507
Loans:
Total loans		5,908
Commercial loans
Loans:
Total loans	1,276,156
Allowance for credit losses	(15,351)
Loans:
Total loans		1,187,543
Allowance for credit losses		(15,254)
Residential mortgage loans
Loans:
Total loans	628,628
Allowance for credit losses	(6,431)
Loans:
Total loans		605,091
Allowance for credit losses		(5,450)
Consumer loans
Loans:
Total loans	72,189
Allowance for credit losses	(960)
Loans:
Total loans		78,164
Allowance for credit losses		(990)
Residential construction loans
Loans:
Total loans	133,450
Allowance for credit losses	$ (1,520)
Loans:
Total loans		163,457
Allowance for credit losses		$ (2,627)

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) (Unaudited) - shares shares in Thousands	Sep. 30, 2023	Dec. 31, 2022
Consolidated Balance Sheets (Unaudited)
Common stock, shares issued (in shares)	11,411	11,289
Common stock, shares outstanding (in shares)	10,115	10,584
Treasury shares	1,296	705

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
INTEREST INCOME
Interest-bearing deposits	$ 483	$ 168	$ 1,257	$ 416
FHLB stock	364	93	1,037	176
Securities:
Taxable	1,848	1,397	5,385	3,164
Tax-exempt	17	18	55	34
Total securities	1,865	1,415	5,440	3,198
Loans:
SBA loans	1,379	1,083	4,186	2,933
SBA PPP loans	25	277	129	1,546
Commercial loans	20,299	14,017	56,320	37,928
Residential mortgage loans	8,462	5,912	25,103	15,284
Consumer loans	1,525	1,075	4,351	2,914
Residential construction loans	2,588	2,184	7,911	6,018
Total loans	34,278	24,548	98,000	66,623
Total interest income	36,990	26,224	105,734	70,413
INTEREST EXPENSE
Interest-bearing demand deposits	1,429	320	3,761	682
Savings deposits	3,178	878	7,632	1,635
Time deposits	5,033	600	11,637	1,499
Borrowed funds and subordinated debentures	3,817	688	11,740	1,199
Total interest expense	13,457	2,486	34,770	5,015
Net interest income	23,533	23,738	70,964	65,398
Provision for credit losses	534	1,517	1,419	2,526
Net interest income after provision for credit losses	22,999	22,221	69,545	62,872
NONINTEREST INCOME
Gain on sale of SBA loans held for sale, net			896	852
Gain on sale of mortgage loans, net	488	280	1,195	1,231
BOLI income	679	170	843	494
Net security losses	(123)	(576)	(610)	(1,631)
Other income	336	357	1,131	2,446
Total noninterest income	2,043	1,110	5,575	6,099
NONINTEREST EXPENSE
Compensation and benefits	7,440	6,471	21,801	19,790
Processing and communications	705	708	2,172	2,166
Occupancy	763	702	2,312	2,205
Furniture and equipment	645	617	2,024	1,811
Professional services	348	221	1,071	1,060
Advertising	405	307	1,108	873
Other loan expenses	125	109	298	238
Deposit insurance	397	233	1,362	752
Director fees	209	240	629	698
Loan collection expenses	90	45	222	138
Other expenses	868	411	2,175	1,454
Total noninterest expense	11,995	10,064	35,174	31,185
Income before provision for income taxes	13,047	13,267	39,946	37,786
Provision for income taxes	3,097	3,325	10,009	9,285
Net income	$ 9,950	$ 9,942	$ 29,937	$ 28,501
Net income per common share - Basic	$ 0.98	$ 0.94	$ 2.92	$ 2.72
Net income per common share - Diluted	$ 0.97	$ 0.93	$ 2.88	$ 2.67
Weighted average common shares outstanding - Basic (in shares)	10,128	10,522	10,255	10,491
Weighted average common shares outstanding - Diluted	10,258	10,714	10,381	10,694
Branch fee income
NONINTEREST INCOME
Noninterest income	$ 278	$ 336	$ 741	$ 892
Service and loan fee income
NONINTEREST INCOME
Noninterest income	$ 385	$ 543	$ 1,379	$ 1,815

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Consolidated Statements of Comprehensive Income (Unaudited)
Net income, before tax amount	$ 13,047	$ 13,267	$ 39,946	$ 37,786
Income tax expense (benefit)	3,097	3,325	10,009	9,285
Net income	9,950	9,942	29,937	28,501
Debt securities available for sale:
Unrealized holding losses on securities arising during the period, before tax	(342)	(1,238)	(660)	(6,875)
Unrealized holding losses on securities arising during the period, tax	(87)	(281)	(155)	(1,612)
Unrealized holding losses on securities arising during the period, net	(255)	(957)	(505)	(5,263)
Less: reclassification adjustment for losses on securities included in net income, before tax		(576)		(1,630)
Less: reclassification adjustment for losses on securities included in net income, tax		(121)		(342)
Less: reclassification adjustment for losses on securities included in net income, net of tax		(455)		(1,288)
Total unrealized losses on securities available for sale, before tax	(342)	(662)	(660)	(5,245)
Total unrealized losses on securities available for sale, tax	(87)	(160)	(155)	(1,270)
Total unrealized losses on securities available for sale, net of tax	(255)	(502)	(505)	(3,975)
Net unrealized (losses) gains from cash flow hedges:
Unrealized holding (losses) gains on cash flow hedges arising during the period, before tax	(377)	452	(929)	1,190
Unrealized holding (losses) gains on cash flow hedges arising during the period, tax	(125)	128	(265)	337
Unrealized holding (losses) gains on cash flow hedges arising during the period, net of tax	(252)	324	(664)	853
Less: reclassification adjustment for (gains) on cash flow hedges included in net income, before tax	(238)		(656)
Less: reclassification adjustment for (gains) on cash flow hedges included in net income, tax	(68)		(187)
Less: reclassification adjustment for (gains) on cash flow hedges included in net income, net of tax	(170)		(469)
Total unrealized (losses) gains on cash flow hedges, before tax	(139)	452	(273)	1,190
Total unrealized (losses) gains on cash flow hedges, tax	(57)	128	(78)	337
Total unrealized (losses) gains on cash flow hedges, net of tax	(82)	324	(195)	853
Total other comprehensive loss, before tax	(481)	(210)	(933)	(4,055)
Total other comprehensive loss, tax	(144)	(32)	(233)	(933)
Total other comprehensive loss, net of tax	(337)	(178)	(700)	(3,122)
Total comprehensive income, before tax	12,566	13,057	39,013	33,731
Total comprehensive income, tax	2,953	3,293	9,776	8,352
Total comprehensive income, net of tax	$ 9,613	$ 9,764	$ 29,237	$ 25,379

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands		Common stock	Retained earnings Cumulative Effect, Period of Adoption, Adjustment	Retained earnings	Treasury stock	Accumulated other comprehensive (loss) income	Cumulative Effect, Period of Adoption, Adjustment	Total
Beginning Balance (in shares) at Dec. 31, 2021		10,391
Beginning balance at Dec. 31, 2021		$ 94,003		$ 123,037	$ (11,633)	$ 322		$ 205,729
Increase (Decrease) in Stockholders' Equity
Net income				9,108				9,108
Other comprehensive income, net of tax						286		286
Dividends on common stock ($0.12 per share)		$ 37		(1,045)				(1,008)
Share-based compensation (1) (in shares)	[1]	102
Share-based compensation (1)	[1]	$ 813						813
Ending Balance (in shares) at Mar. 31, 2022		10,493
Ending balance at Mar. 31, 2022		$ 94,853		131,100	(11,633)	608		214,928
Beginning Balance (in shares) at Dec. 31, 2021		10,391
Beginning balance at Dec. 31, 2021		$ 94,003		123,037	(11,633)	322		205,729
Increase (Decrease) in Stockholders' Equity
Net income								28,501
Other comprehensive income, net of tax						(3,122)		(3,122)
Ending Balance (in shares) at Sep. 30, 2022		10,533
Ending balance at Sep. 30, 2022		$ 96,493		148,174	(11,633)	(2,800)		230,234
Beginning Balance (in shares) at Mar. 31, 2022		10,493
Beginning balance at Mar. 31, 2022		$ 94,853		131,100	(11,633)	608		214,928
Increase (Decrease) in Stockholders' Equity
Net income				9,451				9,451
Other comprehensive income, net of tax						(3,230)		(3,230)
Dividends on common stock ($0.12 per share)		$ 43		(1,157)				(1,114)
Share-based compensation (1) (in shares)	[1]	18
Share-based compensation (1)	[1]	$ 754						754
Ending Balance (in shares) at Jun. 30, 2022		10,511
Ending balance at Jun. 30, 2022		$ 95,650		139,394	(11,633)	(2,622)		220,789
Increase (Decrease) in Stockholders' Equity
Net income				9,942				9,942
Other comprehensive income, net of tax						(178)		(178)
Dividends on common stock ($0.12 per share)		$ 41		(1,162)				(1,121)
Share-based compensation (1) (in shares)	[1]	22
Share-based compensation (1)	[1]	$ 802						802
Ending Balance (in shares) at Sep. 30, 2022		10,533
Ending balance at Sep. 30, 2022		$ 96,493		148,174	(11,633)	(2,800)		230,234
Increase (Decrease) in Stockholders' Equity
Effect of adopting Accounting Standards Update ("ASU") No. 2016-13 ("CECL")								$ (156,958)
Beginning Balance (in shares) at Dec. 31, 2022		10,584						10,584
Beginning balance at Dec. 31, 2022		$ 97,204		156,958	(11,675)	(3,260)		$ 239,227
Increase (Decrease) in Stockholders' Equity
Net income				10,287				10,287
Other comprehensive income, net of tax						81		81
Dividends on common stock ($0.12 per share) (in shares)		2
Dividends on common stock ($0.12 per share)		$ 46		(1,261)				(1,215)
Share-based compensation (1) (in shares)	[1]	44
Share-based compensation (1)	[1]	$ 947						947
Treasury stock purchased, at cost (2) (in shares)		(338)
Treasury stock purchased, at cost (2)					(8,219)			(8,219)
Ending Balance (in shares) at Mar. 31, 2023		10,292
Ending balance at Mar. 31, 2023		$ 98,197	$ 649	165,335	(19,894)	(3,179)	$ 649	$ 240,459
Beginning Balance (in shares) at Dec. 31, 2022		10,584						10,584
Beginning balance at Dec. 31, 2022		$ 97,204		156,958	(11,675)	(3,260)		$ 239,227
Increase (Decrease) in Stockholders' Equity
Net income								29,937
Other comprehensive income, net of tax						(700)		$ (700)
Ending Balance (in shares) at Sep. 30, 2023		10,115						10,115
Ending balance at Sep. 30, 2023		$ 99,741		182,557	(25,954)	(3,960)		$ 252,384
Beginning Balance (in shares) at Mar. 31, 2023		10,292
Beginning balance at Mar. 31, 2023		$ 98,197	$ 649	165,335	(19,894)	(3,179)	$ 649	240,459
Increase (Decrease) in Stockholders' Equity
Net income				9,700				9,700
Other comprehensive income, net of tax						(444)		(444)
Dividends on common stock ($0.12 per share) (in shares)		2
Dividends on common stock ($0.12 per share)		$ 47		(1,212)				(1,165)
Share-based compensation (1) (in shares)	[1]	50
Share-based compensation (1)	[1]	$ 666						666
Treasury stock purchased, at cost (2) (in shares)		(225)
Treasury stock purchased, at cost (2)					(5,143)			(5,143)
Ending Balance (in shares) at Jun. 30, 2023		10,119
Ending balance at Jun. 30, 2023		$ 98,910		173,823	(25,037)	(3,623)		244,073
Increase (Decrease) in Stockholders' Equity
Net income				9,950				9,950
Other comprehensive income, net of tax						(337)		(337)
Dividends on common stock ($0.12 per share) (in shares)		2
Dividends on common stock ($0.12 per share)		$ 47		(1,216)				(1,169)
Share-based compensation (1) (in shares)	[1]	22
Share-based compensation (1)	[1]	$ 784						784
Treasury stock purchased, at cost (2) (in shares)	[2]	(28)
Treasury stock purchased, at cost (2)	[2]				(917)			$ (917)
Ending Balance (in shares) at Sep. 30, 2023		10,115						10,115
Ending balance at Sep. 30, 2023		$ 99,741		$ 182,557	$ (25,954)	$ (3,960)		$ 252,384
Increase (Decrease) in Stockholders' Equity
Effect of adopting Accounting Standards Update ("ASU") No. 2016-13 ("CECL")								$ (182,557)
[1] Includes the issuance of common stock under employee benefit plans, which includes nonqualified stock options and restricted stock expense related entries, employee option exercises and the tax benefit of options exercised. Includes an excise tax accrual of $0.1 million.

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Shareholders' Equity (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Consolidated Statements of Changes in Shareholders' Equity (Unaudited)
Common stock, dividends, per share, cash paid (in dollars per share)	$ 0.12	$ 0.12	$ 0.12	$ 0.11	$ 0.11	$ 0.10
Excise tax accrual	$ 0.1

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
OPERATING ACTIVITIES:
Net income	$ 29,937,000	$ 28,501,000
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	1,419,000	2,526,000
Net amortization of purchase premiums and discounts on securities	(195,000)	26,000
Depreciation and amortization	2,078,000	2,112,000
PPP deferred fees and costs	(90,000)	(1,376,000)
Deferred income tax benefit	(522,000)	(2,064,000)
Net realized security gains	(243,000)
Stock compensation expense	1,269,000	1,239,000
Gain on sale of mortgage loans, net	(1,195,000)	(1,231,000)
Gain on sale of SBA loans held for sale, net	(896,000)	(852,000)
BOLI income	(843,000)	(494,000)
Net change in other assets and liabilities	(8,712,000)	(18,830,000)
Net cash provided by operating activities	22,007,000	9,557,000
INVESTING ACTIVITIES
Purchases of securities held to maturity		(26,748,000)
Purchases of equity securities	(126,000)	(1,539,000)
Purchases of securities available for sale	(650,000)	(45,249,000)
Purchases of FHLB stock, at cost	(818,000)	(10,848,000)
Maturities and principal payments on securities held to maturity		5,185,000
Maturities, calls and principal payments on securities available for sale	3,259,000	3,901,000
Proceeds from sales of equity securities	1,338,000
Net decrease in SBA PPP loans	3,491,000	41,123,000
Net increase in loans	(69,742,000)	(332,650,000)
Proceeds from BOLI	2,397,000	468,000
Purchases of premises and equipment	(794,000)	(240,000)
Net cash used in investing activities	(61,645,000)	(366,597,000)
FINANCING ACTIVITIES
Net increase in deposits	97,382,000	37,716,000
Net proceeds from borrowings	5,610,000	240,000,000
Proceeds from exercise of stock options	1,393,551	1,394,809
Fair market value of shares withheld to cover employee tax liability	(266,000)	(266,000)
Dividends on common stock	(3,549,000)	(3,243,000)
Purchase of treasury stock, including exise tax accrual	(14,279,000)
Net cash provided by financing activities	86,292,000	275,602,000
Increase (decrease) in cash and cash equivalents	46,654,000	(81,438,000)
Cash and cash equivalents, beginning of year	114,793,000	244,818,000
Cash and cash equivalents, end of period	161,447,000	163,380,000
SUPPLEMENTAL DISCLOSURES
Interest paid	34,049,000	4,851,000
Income taxes paid	10,101,000	9,357,000
Noncash activities:
Establishment of lease liability and right-of-use asset		582,000
Capitalization of servicing rights	430,000	$ 131,000
Transfer of loans to OREO	$ 251,000

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Significant Accounting Policies
Significant Accounting Policies	NOTE 1. Significant Accounting Policies The accompanying Consolidated Financial Statements include the accounts of Unity Bancorp, Inc. (the "Parent Company") and its wholly-owned subsidiary, Unity Bank (the "Bank" or when consolidated with the Parent Company, the "Company"). The Bank has multiple subsidiaries used to hold part of its investment and loan portfolios. All significant intercompany balances and transactions have been eliminated in consolidation. Certain reclassifications have been made to prior period amounts to conform to the current year presentation, with no impact on current earnings or shareholders’ equity. The financial information has been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and has not been audited. In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and revenues and expenses during the reporting periods. Actual results could differ from those estimates. Amounts requiring the use of significant estimates include the allowance for credit losses, valuation of deferred tax and servicing assets, the valuation of securities and the determination of impairment for securities and fair value disclosures. Management believes that the allowance for credit losses is adequate. While management uses available information to recognize credit losses, future additions to the allowance for credit losses may be necessary based on changes in economic conditions and the general credit quality of the loan portfolio. The interim unaudited Consolidated Financial Statements included herein have been prepared in accordance with instructions for Form 10-Q and the rules and regulations of the Securities and Exchange Commission (“SEC”) and consist of normal recurring adjustments, that in the opinion of management, are necessary for the fair presentation of interim results. The results of operations for the nine months ended September 30, 2023 are not necessarily indicative of the results which may be expected for the entire year. As used in this Form 10-Q, “we” and “us” and “our” refer to Unity Bancorp, Inc., and its consolidated subsidiary, Unity Bank, depending on the context. Certain information and financial disclosures required by U.S. GAAP have been condensed or omitted from interim reporting pursuant to SEC rules. Interim financial statements should be read in conjunction with the Company’s Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Risks and Uncertainties Overall, the markets and customers serviced by the Company may be significantly impacted by ongoing macro-economic trends, such as inflation and recessionary pressures created by a higher interest rate environment. The Company assesses the impact of inflation on an ongoing basis. Market conditions and external factors may unpredictably impact the competitive landscape for deposits in the banking industry. Additionally, the rising interest rate environment has increased competition for liquidity and the premium at which liquidity is available to meet funding needs. The Company believes the sources of liquidity presented in the Unaudited Consolidated Financial Statements and the Notes to the Unaudited Consolidated Financial Statements are sufficient to meet its needs as of the balance sheet date. An unexpected influx of withdrawals of deposits could adversely impact the Company's ability to rely on organic deposits to primarily fund its operations, potentially requiring greater reliance on secondary sources of liquidity to meet withdrawal demands or to fund continuing operations. These sources may include proceeds from Federal Home Loan Bank advances, sales of investment securities and loans, federal funds lines of credit from correspondent banks and out-of-market time deposits. Such reliance on secondary funding sources could increase the Company's overall cost of funding and thereby reduce net income. While the Company believes its current sources of liquidity are adequate to fund operations, there is no guarantee they will suffice to meet future liquidity demands. This may necessitate slowing or discontinuing loan growth, capital expenditures or other investments, or liquidating assets. New Accounting Guidance adopted in 2023 Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” amends the accounting guidance on the impairment of financial instruments. The Financial Accounting Standards Board (“FASB”) issued an amendment to replace the incurred loss impairment methodology under prior accounting guidance with a new current expected credit loss (“CECL”) model. Under the new guidance, the Company is required to measure expected credit losses by utilizing forward-looking information to assess its allowance for credit losses. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. The measurement of expected credit losses under CECL methodology is applicable to financial assets measured at amortized cost, including loans and held to maturity debt securities. CECL also applies to certain off-balance sheet exposures. ​ The Company adopted ASU 2016-13 on January 1, 2023, using the modified retrospective approach for all financial assets measured at amortized cost and off-balance sheet credit exposures. The Company established a governance structure to implement the CECL accounting guidance and has developed a methodology and set of models to be used upon adoption. At adoption, the Company recorded an $0.8 million increase to its allowance for credit losses, entirely related to loans. Further the Company increased its reserve for unfunded credit commitments by $0.1 million. The reserve for unfunded credit commitments is recorded in Accrued expenses and other liabilities on the consolidated balance sheet. These increases in reserves were recorded through retained earnings and was $0.6 million, net of tax. ​ For available for sale securities in an unrealized loss position, the Company first assesses whether it intends to sell, or is more likely than not that it will be required to sell the security before the recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to fair value through income. For securities available for sale that do not meet the above criteria, the Company evaluates whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost and adverse conditions related to the security, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized cost. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income, net of tax. The Company elected the practical expedient of zero loss estimates for securities issued by U.S. government entities and agencies. These securities are either explicitly or implicitly guaranteed by the U.S. government, are highly rated by major agencies and have a long history of no credit losses. ​ For other assets within the scope of the new CECL accounting guidance, such as held to maturity debt securities and other receivables, management noted the impact from adoption to be inconsequential. Additionally, the Company noted the adoption of CECL had no significant impact on regulatory capital ratios of the Company and/or the Bank. ​ ASU 2022-01, “Derivatives and Hedging (Topic 815)”: ASU 2022-01 was issued to clarify the guidance in ASC 815 on fair value hedge accounting of interest rate risk for portfolios and financial assets. Among other things, the amended guidance established the “last-of-layer” method for making the fair value hedge accounting for these portfolios more accessible and renamed that method the “portfolio layer” method. ASU 2022-01 is effective January 1, 2023. The Company adopted the guidance effective January 1, 2023, noting no material impact. ​ ASU 2022-02, “Financial Instruments – Credit Losses (Topic 326)”: ASU 2022-02 eliminates the guidance on troubled debt restructurings (“TDRs”) and requires entities to evaluate all loan modifications to determine if they result in a new loan or a continuation of the existing loan. ASU 2022-02 requires that entities disclose if the modifications result in a new loan or a continuation of the existing loan. ASU 2022-02 also requires that entities disclose current-period gross charge-offs by year of origination for loans and leases. The Company adopted ASU 2022-02 effective January 1, 2023, noting no material impact. ​ ​

Litigation

Litigation	9 Months Ended
	Sep. 30, 2023
Litigation
Litigation	NOTE 2. Litigation The Company may, in the ordinary course of business, become a party to litigation involving collection matters, contract claims and other legal proceedings relating to the conduct of its business. In the best judgment of management, based upon consultation with counsel, the consolidated financial position and results of operations of the Company will not be affected materially by the final outcome of any pending legal proceedings or other contingent liabilities and commitments.

Net Income per Share

Net Income per Share	9 Months Ended
	Sep. 30, 2023
Net Income per Share
Net Income per Share	NOTE 3. Net Income per Share Basic net income per common share is calculated as net income divided by the weighted average common shares outstanding during the reporting period. Common shares include vested and unvested restricted shares. Diluted net income per common share is computed similarly to that of basic net income per common share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if all potentially dilutive common shares, principally stock options, were issued during the reporting period utilizing the treasury stock method. The following is a reconciliation of the calculation of basic and diluted income per share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ ​ For the nine months ended September 30, (In thousands, except per share amounts) 2023 2022 ​ 2023 2022 Net income ​ $ 9,950 ​ $ 9,942 ​ ​ $ 29,937 ​ $ 28,501 Weighted average common shares outstanding - Basic ​ 10,128 ​ 10,522 ​ ​ 10,255 ​ 10,491 Plus: Potential dilutive common stock equivalents ​ 130 ​ 192 ​ ​ 126 ​ 203 Weighted average common shares outstanding - Diluted ​ 10,258 ​ 10,714 ​ ​ 10,381 ​ 10,694 Net income per common share - Basic ​ $ 0.98 ​ $ 0.94 ​ ​ $ 2.92 ​ $ 2.72 Net income per common share - Diluted ​ 0.97 ​ 0.93 ​ ​ 2.88 ​ 2.67 Stock options and common stock excluded from the income per share calculation as their effect would have been anti-dilutive ​ — ​ — ​ ​ — ​ — ​

Other Comprehensive (Loss) Inco

Other Comprehensive (Loss) Income	9 Months Ended
	Sep. 30, 2023
Other Comprehensive (Loss) Income
Other Comprehensive (Loss) Income	NOTE 4. Other Comprehensive (Loss) Income The following tables show the changes in other comprehensive (loss) income for the three and nine months ended September 30, 2023 and 2022, net of tax: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, 2023 ​ ​ ​ Accumulated ​ Net unrealized Net unrealized other ​ losses on gains (losses) from comprehensive (In thousands) ​ securities cash flow hedges loss Balance, beginning of period ​ $ (4,631) ​ $ 1,008 ​ $ (3,623) Other comprehensive loss before reclassifications ​ (255) ​ ​ (252) ​ (507) Less amounts reclassified from accumulated other comprehensive loss ​ — ​ ​ (170) ​ (170) Period change ​ (255) ​ (82) ​ (337) Balance, end of period ​ $ (4,886) ​ $ 926 ​ $ (3,960) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, 2022 ​ ​ ​ Net unrealized Accumulated ​ Net unrealized gains other ​ losses on from cash flow comprehensive (In thousands) securities hedges loss Balance, beginning of period ​ $ (3,444) ​ $ 822 ​ $ (2,622) Other comprehensive (loss) income before reclassifications ​ (957) ​ ​ 324 ​ ​ (633) Less amounts reclassified from accumulated other comprehensive loss ​ (455) ​ ​ — ​ ​ (455) Period change ​ (502) ​ ​ 324 ​ ​ (178) Balance, end of period ​ $ (3,946) ​ $ 1,146 ​ $ (2,800) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the nine months ended September 30, 2023 ​ ​ ​ Net unrealized Accumulated ​ ​ Net unrealized gains (losses) other ​ ​ (losses) on from cash flow comprehensive (In thousands) ​ securities hedges loss Balance, beginning of period ​ $ (4,381) ​ $ 1,121 ​ $ (3,260) Other comprehensive loss before reclassifications ​ (505) ​ ​ (664) ​ (1,169) Less amounts reclassified from accumulated other comprehensive loss ​ — ​ ​ (469) ​ (469) Period change ​ (505) ​ (195) ​ (700) Balance, end of period ​ $ (4,886) ​ $ 926 ​ $ (3,960) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the nine months ended September 30, 2022 ​ ​ Net unrealized Accumulated ​ Net unrealized gains other ​ ​ gains (losses) on from cash flow comprehensive (In thousands) ​ securities hedges income (loss) Balance, beginning of period ​ $ 29 ​ $ 293 ​ $ 322 Other comprehensive (loss) income before reclassifications ​ (5,263) ​ ​ 853 ​ (4,410) Less amounts reclassified from accumulated other comprehensive loss ​ (1,288) ​ ​ — ​ (1,288) Period change ​ (3,975) ​ 853 ​ (3,122) Balance, end of period ​ $ (3,946) ​ $ 1,146 ​ $ (2,800)

Fair Value

Fair Value	9 Months Ended
	Sep. 30, 2023
Fair Value
Fair Value	​ NOTE 5. Fair Value Fair Value Measurement The Company follows FASB ASC Topic 820, “Fair Value Measurement and Disclosures,” Level 1 Inputs ● Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. ● Generally, this includes debt and equity securities and derivative contracts that are traded in an active exchange market (i.e. New York Stock Exchange), as well as certain U.S. Treasury, U.S. Government and sponsored entity agency mortgage-backed securities that are highly liquid and are actively traded in over-the-counter markets. ​ Level 2 Inputs ● Quoted prices for similar assets or liabilities in active markets. ● Quoted prices for identical or similar assets or liabilities in inactive markets. ● Inputs other than quoted prices that are observable, either directly or indirectly, for the term of the asset or liability (i.e. interest rates, yield curves, credit risks, prepayment speeds or volatilities) or “market corroborated inputs.” ● Generally, this includes U.S. Government and sponsored entity mortgage-backed securities, corporate debt securities and derivative contracts. ​ Level 3 Inputs ● Prices or valuation techniques that require inputs that are both unobservable (i.e. supported by little or no market activity) and that are significant to the fair value of the assets or liabilities. ● These assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. ​ Fair Value on a Recurring Basis The following is a description of the valuation methodologies used for instruments measured at fair value on a recurring basis: Debt Securities Available for Sale The fair value of available for sale ("AFS") debt securities is the market value based on quoted market prices, when available, or market prices provided by recognized broker dealers (Level 1). If listed prices or quotes are not available, fair value is based upon quoted market prices for similar or identical assets or other observable inputs (Level 2) or externally developed models that use unobservable inputs due to limited or no market activity of the instrument (Level 3). As of September 30, 2023, the fair value of the Company’s AFS debt securities portfolio was $92.1 million. Most of the Company’s AFS debt securities were classified as Level 2 assets at September 30, 2023. The valuation of AFS debt securities using Level 2 inputs was primarily determined using the market approach, which uses quoted prices for similar assets or liabilities in active markets and all other relevant information. It includes model pricing, defined as valuing securities based upon their relationship with other benchmark securities. Included in the Company’s AFS debt securities are two corporate bonds which are classified as Level 3 assets at September 30, 2023. The valuation of these corporate bonds is determined using broker quotes or third-party vendor prices that are not adjusted by management. Market inputs used in the other valuation techniques or underlying third-party vendor prices or broker quotes include benchmark and government bond yield curves, credit spreads and trade execution data. Equity Securities with Readily Determinable Fair Values The fair value of equity securities is the market value based on quoted market prices, when available, or market prices provided by recognized broker dealers (Level 1). If listed prices or quotes are not available, fair value is based upon quoted market prices for similar or identical assets or other observable inputs (Level 2) or externally developed models that use unobservable inputs due to limited or no market activity of the instrument (Level 3). As of September 30, 2023, the fair value of the Company’s equity securities portfolio was $8.0 million. All of the Company’s equity securities were classified as Level 1 assets at September 30, 2023. Interest Rate Swap Agreements The fair value of interest rate swap agreements is the market value based on quoted market prices, when available, or market prices provided by recognized broker dealers (Level 1). If listed prices or quotes are not available, fair value is based upon quoted market prices for similar or identical assets or other observable inputs (Level 2) or externally developed models that use unobservable inputs due to limited or no market activity of the instrument (Level 3). The Company’s derivative instruments are classified as Level 2 assets, as the readily observable market inputs to these models are validated to external sources, such as industry pricing services, or are corroborated through recent trades, dealer quotes, yield curves, implied volatility or other market-related data. There were no material changes in the inputs or methodologies used to determine fair value during the period ended September 30, 2023, as compared to the periods ended December 31, 2022 and September 30, 2022. ​ The tables below present the balances of assets and liabilities measured at fair value on a recurring basis as of September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measurements at September 30, 2023 ​ ​ ​ ​ ​ Quoted Prices in ​ ​ ​ ​ ​ ​ ​ ​ Assets/Liabilities ​ Active Markets ​ Significant Other ​ Significant ​ ​ Measured at Fair ​ for Identical ​ Observable ​ Unobservable (In thousands) Value Assets (Level 1) Inputs (Level 2) Inputs (Level 3) Measured on a recurring basis: ​ ​ ​ ​ Assets: ​ ​ ​ ​ Debt securities available for sale: ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 16,325 ​ $ — ​ $ 16,325 ​ $ — State and political subdivisions ​ ​ 362 ​ ​ — ​ ​ 362 ​ ​ — Residential mortgage-backed securities ​ 13,670 ​ — ​ 13,670 ​ — Corporate and other securities ​ 61,765 ​ — ​ 57,502 ​ 4,263 Total debt securities available for sale ​ $ 92,122 ​ $ — ​ $ 87,859 ​ $ 4,263 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Equity securities with readily determinable fair values ​ 8,013 ​ 8,013 ​ — ​ — Total equity securities ​ $ 8,013 ​ $ 8,013 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest rate swap agreements ​ 1,264 ​ — ​ 1,264 ​ — Total swap agreements ​ $ 1,264 ​ $ — ​ $ 1,264 ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair value Measurements at December 31, 2022 ​ ​ ​ ​ ​ Quoted Prices in ​ ​ ​ ​ ​ ​ ​ ​ Assets/Liabilities ​ Active Markets ​ Significant Other ​ Significant ​ ​ Measured at Fair ​ for Identical ​ Observable ​ Unobservable (In thousands) Value Assets (Level 1) Inputs (Level 2) Inputs (Level 3) Measured on a recurring basis: ​ ​ ​ ​ Assets: ​ ​ ​ ​ Debt securities available for sale: ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 16,305 ​ $ — ​ $ 16,305 ​ $ — State and political subdivisions ​ 613 ​ ​ — ​ ​ 613 ​ ​ — Residential mortgage-backed securities ​ 15,475 ​ — ​ 15,475 ​ — Corporate and other securities ​ 63,000 ​ — ​ 58,325 ​ 4,675 Total debt securities available for sale ​ $ 95,393 ​ $ — ​ $ 90,718 ​ $ 4,675 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Equity securities with readily determinable fair values ​ 9,793 ​ — ​ 9,793 ​ — Total equity securities ​ $ 9,793 ​ $ — ​ $ 9,793 ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest rate swap agreements ​ 1,537 ​ — ​ 1,537 ​ — Total swap agreements ​ $ 1,537 ​ $ — ​ $ 1,537 ​ $ — ​ There were no liabilities measured on a recurring basis as of September 30, 2023 or December 31, 2022. Fair Value on a Nonrecurring Basis The following tables present the assets and liabilities subject to fair value adjustments on a non-recurring basis carried on the balance sheet by caption and by level within the hierarchy (as described above): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measurements at September 30, 2023 ​ ​ ​ ​ ​ Quoted Prices ​ Significant ​ ​ ​ ​ ​ ​ ​ ​ in Active ​ Other ​ Significant ​ ​ Assets/Liabilities ​ Markets for ​ Observable ​ Unobservable ​ ​ Measured at Fair ​ Identical Assets ​ Inputs ​ Inputs (In thousands) Value (Level 1) (Level 2) (Level 3) Measured on a non-recurring basis: ​ ​ ​ ​ Financial assets: ​ ​ ​ ​ OREO ​ $ 251 ​ $ — ​ $ — ​ $ 251 Collateral-dependent loans ​ $ 13,738 ​ $ — ​ $ — ​ $ 13,738 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measurements at December 31, 2022 ​ ​ ​ ​ ​ Quoted Prices ​ Significant ​ ​ ​ ​ ​ ​ ​ ​ in Active ​ Other ​ Significant ​ ​ Assets/Liabilities ​ Markets for ​ Observable ​ Unobservable ​ ​ Measured at Fair ​ Identical Assets ​ Inputs ​ Inputs (In thousands) Value (Level 1) (Level 2) (Level 3) Measured on a non-recurring basis: ​ ​ ​ ​ Financial assets: ​ ​ ​ ​ Collateral-dependent loans ​ $ 8,803 ​ $ — ​ $ — ​ $ 8,803 ​ Certain assets and liabilities are not measured at fair value on an ongoing basis but are subject to fair value adjustments in certain circumstances (for example, when there is evidence of impairment). The following is a description of the valuation methodologies used for instruments measured at fair value on a nonrecurring basis: Collateral-Dependent Loans & OREO Fair value is determined based on the fair value of the collateral. Partially charged-off loans are measured for impairment based upon a third-party appraisal for collateral-dependent loans. When an updated appraisal is received for a nonperforming loan, the value on the appraisal may be discounted. If there is a deficiency in the value after the Company applies these discounts, management applies a specific reserve and the loan remains in nonaccrual status. The receipt of an updated appraisal would not qualify as a reason to put a loan back into accruing status. The Company removes loans from nonaccrual status generally when the borrower makes six months of contractual payments and demonstrates the ability to service the debt going forward. Charge-offs are determined based upon the loss that management believes the Company will incur after evaluating collateral for impairment based upon the valuation methods described above and the ability of the borrower to pay any deficiency. The valuation allowance for individually evaluated loans is included in the allowance for credit losses in the consolidated balance sheets. At September 30, 2023, the valuation allowance for individually evaluated loans was $1.7 million, compared to $1.8 million at December 31, 2022. Fair Value of Financial Instruments FASB ASC Topic 825, “Financial Instruments,” realize in a current market exchange. The use of alternative market assumptions and estimation methodologies could have had a material effect on these estimates of fair value. The methodology for estimating the fair value of financial assets and liabilities that are measured on a recurring or nonrecurring basis are discussed above. The following methods and assumptions were used to estimate the fair value of other financial instruments for which it is practicable to estimate that value: Securities The fair value of securities is based upon quoted market prices for similar or identical assets or other observable inputs (Level 2) or externally developed models that use unobservable inputs due to limited or no market activity of the instrument (Level 3). SBA Loans Held for Sale The fair value of SBA loans held for sale is estimated by using a market approach that includes significant other observable inputs. Loans The fair value of loans is estimated by discounting the future cash flows using current market rates that reflect the interest rate risk inherent in the loan, except for previously discussed impaired loans. Deposit Liabilities The fair value of demand deposits and savings accounts is the amount payable on demand at the reporting date (i.e. carrying value). The fair value of fixed-maturity certificates of deposit is estimated by discounting the future cash flows using current market rates. Borrowed Funds and Subordinated Debentures The fair value of borrowings is estimated by discounting the projected future cash flows using current market rates. The table below presents the carrying amount and estimated fair values of the Company’s financial instruments presented as of September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2023 ​ Carrying ​ ​ ​ ​ ​ ​ (In thousands) amount Level 1 Level 2 Level 3 Financial assets: ​ ​ ​ ​ Debt securities held to maturity $ 35,956 ​ $ — ​ $ 27,155 ​ $ — SBA loans held for sale 19,387 ​ — ​ 20,322 ​ — Loans, net of allowance for credit losses 2,127,885 ​ — ​ — ​ 2,027,127 Financial liabilities: ​ ​ ​ ​ ​ ​ ​ Deposits 1,884,910 ​ — ​ 1,871,627 ​ — Borrowed funds and subordinated debentures 398,920 ​ — ​ 397,323 ​ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 ​ Carrying ​ ​ ​ ​ ​ ​ (In thousands) amount Level 1 Level 2 Level 3 Financial assets: ​ ​ ​ ​ Debt securities held to maturity $ 35,760 ​ $ — ​ $ 28,578 ​ $ — SBA loans held for sale 27,928 ​ — ​ 30,141 ​ — Loans, net of allowance for credit losses 2,053,435 ​ — ​ 1,981,207 ​ 8,803 Financial liabilities: ​ ​ ​ ​ ​ ​ ​ Deposits 1,787,528 ​ — ​ 1,772,270 ​ — Borrowed funds and subordinated debentures 393,310 ​ — ​ 391,312 ​ — ​ ​ Limitations Fair value estimates are made at a point in time, based on relevant market information and information about the financial instrument. These estimates do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument. Because no market exists for a significant portion of the Company’s financial instruments, fair value estimates are based on judgments regarding future expected loss experience, current economic conditions, risk characteristics of various financial instruments and other factors. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates. Fair value estimates are based on existing on- and off-balance sheet financial instruments without attempting to estimate the value of anticipated future business and the value of assets and liabilities that are not considered financial instruments. In addition, the tax ramifications related to the effect of fair value estimates have not been considered in the above estimates.

Securities

Securities	9 Months Ended
	Sep. 30, 2023
Securities
Securities	NOTE 6. Securities This table provides the major components of debt securities available for sale ("AFS") and held to maturity (“HTM”) at amortized cost and estimated fair value at September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2023 ​ December 31, 2022 ​ ​ ​ Gross Gross ​ ​ ​ ​ Gross Gross ​ ​ ​ ​ Amortized ​ unrealized ​ unrealized ​ Estimated ​ Amortized ​ unrealized ​ unrealized ​ Estimated (In thousands) ​ cost ​ gains ​ losses ​ fair value ​ cost ​ gains ​ losses ​ fair value Available for sale: ​ ​ ​ ​ ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 17,133 ​ $ — ​ $ (808) ​ $ 16,325 ​ $ 16,961 ​ $ — ​ $ (656) ​ $ 16,305 State and political subdivisions ​ 407 ​ — ​ (45) ​ 362 ​ 635 ​ — ​ (22) ​ 613 Residential mortgage-backed securities ​ 15,835 ​ 28 ​ (2,193) ​ 13,670 ​ 17,097 ​ 32 ​ (1,654) ​ 15,475 Corporate and other securities ​ 65,202 ​ 121 ​ (3,558) ​ 61,765 ​ 66,495 ​ 106 ​ (3,601) ​ 63,000 Total debt securities available for sale ​ $ 98,577 ​ $ 149 ​ $ (6,604) ​ $ 92,122 ​ $ 101,188 ​ $ 138 ​ $ (5,933) ​ $ 95,393 Held to maturity: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 28,000 ​ $ — ​ $ (6,096) ​ $ 21,904 ​ $ 28,000 ​ $ — ​ $ (5,310) ​ $ 22,690 State and political subdivisions ​ 1,158 ​ 5 ​ (3) ​ 1,160 ​ 1,115 ​ 67 ​ — ​ 1,182 Residential mortgage-backed securities ​ 6,798 ​ — ​ (2,707) ​ 4,091 ​ 6,645 ​ — ​ (1,939) ​ 4,706 Total debt securities held to maturity ​ $ 35,956 ​ $ 5 ​ $ (8,806) ​ $ 27,155 ​ $ 35,760 ​ $ 67 ​ $ (7,249) ​ $ 28,578 ​ The contractual maturities of available for sale and held for maturity debt securities at September 30, 2023 are set forth in the following table. Maturities may differ from contractual maturities in residential mortgage-backed securities because the mortgages underlying the securities may be prepaid without any penalties. Therefore, residential mortgage-backed securities are not included in the maturity categories in the following summary. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amortized ​ ​ Fair (In thousands) ​ Cost ​ ​ Value Available for sale: ​ ​ ​ ​ Due in one year $ 2,133 ​ $ 2,114 Due after one year through five years ​ 30,779 ​ ​ 29,404 Due after five years through ten years ​ 10,984 ​ ​ 9,616 Due after ten years ​ 38,846 ​ ​ 37,318 Residential mortgage-backed securities ​ 15,835 ​ ​ 13,670 Total $ 98,577 ​ $ 92,122 Held to maturity: ​ ​ ​ ​ ​ Due in one year $ — ​ $ — Due after one year through five years ​ — ​ ​ — Due after five years through ten years ​ 3,000 ​ ​ 2,819 Due after ten years ​ 26,158 ​ ​ 20,245 Residential mortgage-backed securities ​ 6,798 ​ ​ 4,091 Total $ 35,956 ​ $ 27,155 ​ Actual maturities of available for sale and held to maturity debt securities may differ from those presented above since certain obligations provide the issuer the right to call or prepay the obligation prior to scheduled maturitiy without penalty. The fair value of debt securities with unrealized losses by length of time that the individual securities have been in a continuous unrealized loss position at September 30, 2023 and December 31, 2022 are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2023 ​ ​ ​ Less than 12 months ​ 12 months and greater ​ Total ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Estimated ​ Unrealized ​ Estimated ​ Unrealized ​ Estimated ​ Unrealized (In thousands) ​ ​ fair value ​ loss ​ fair value ​ loss ​ fair value ​ loss Available for sale: ​ ​ ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 2,114 ​ $ (19) ​ $ 14,211 ​ $ (789) ​ $ 16,325 ​ $ (808) State and political subdivisions ​ ​ — ​ ​ — ​ ​ 362 ​ ​ (45) ​ ​ 362 ​ ​ (45) Residential mortgage-backed securities ​ ​ 81 ​ ​ (3) ​ ​ 13,543 ​ ​ (2,190) ​ ​ 13,624 ​ ​ (2,193) Corporate and other securities ​ ​ 4,692 ​ ​ (308) ​ ​ 54,452 ​ ​ (3,250) ​ ​ 59,144 ​ ​ (3,558) Total ​ ​ $ 6,887 ​ $ (330) ​ $ 82,568 ​ $ (6,274) ​ $ 89,455 ​ $ (6,604) Held to maturity: ​ ​ ​ ​ ​ ​ U.S. Government sponsored entities ​ $ — ​ $ — ​ $ 21,904 ​ $ (6,096) ​ $ 21,904 ​ $ (6,096) State and political subdivisions ​ ​ ​ 571 ​ ​ (3) ​ ​ — ​ ​ — ​ ​ 571 ​ ​ (3) Residential mortgage-backed securities ​ ​ ​ — ​ $ — ​ ​ 4,091 ​ ​ (2,707) ​ ​ 4,091 ​ ​ (2,707) Total ​ $ 571 ​ $ (3) ​ $ 25,995 ​ $ (8,803) ​ $ 26,566 ​ $ (8,806) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 ​ ​ ​ Less than 12 months ​ 12 months and greater ​ Total ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Estimated ​ Unrealized ​ Estimated ​ Unrealized ​ Estimated ​ Unrealized (In thousands) ​ ​ fair value ​ loss ​ fair value ​ loss ​ fair value ​ loss Available for sale: ​ ​ ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 15,817 ​ $ (622) ​ $ 1,432 ​ $ (34) ​ $ 17,249 ​ $ (656) State and political subdivisions ​ ​ 160 ​ ​ (5) ​ ​ 253 ​ ​ (17) ​ ​ 413 ​ ​ (22) Residential mortgage-backed securities ​ 14,023 ​ ​ (1,448) ​ ​ 1,311 ​ ​ (206) ​ ​ 15,334 ​ ​ (1,654) Corporate and other securities ​ ​ 23,445 ​ (966) ​ 31,948 ​ (2,635) ​ 55,393 ​ (3,601) Total temporarily impaired AFS securities ​ $ 53,445 ​ $ (3,041) ​ $ 34,944 ​ $ (2,892) ​ $ 88,389 ​ $ (5,933) Held to maturity: ​ ​ ​ ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 15,659 ​ $ (2,341) ​ $ 7,031 ​ $ (2,969) ​ $ 22,690 ​ $ (5,310) Residential mortgage-backed securities ​ 4,707 ​ (1,939) ​ — ​ — ​ 4,707 ​ (1,939) Total temporarily impaired HTM securities ​ $ 20,366 ​ $ (4,280) ​ $ 7,031 ​ $ (2,969) ​ $ 27,397 ​ $ (7,249) ​ Unrealized losses in each of the categories presented in the tables above were primarily driven by market interest rate fluctuations. Residential mortgage-backed securities are guaranteed by either Ginnie Mae, Freddie Mac or Fannie Mae. Allowance for Credit Losses The Company has zero-loss expectation for certain securities within the held to maturity portfolio, and therefore is not required to estimate an allowance for credit losses related to these securities under the CECL standard. The Company does not provide credit quality indicators for held to maturity securities that have zero-loss expectation. After an evaluation of various factors, the following security types are believed to qualify for this exclusion: U.S Government sponsored entities and residential mortgage-backed securities issued by Ginnie Mae, Fannie Mae or Freddie Mac. ​ After reviewing credit ratings on securities within the portfolio, management recognized no impairment for held to maturity debt securities during the three and nine months ended September 30, 2023 and 2022. There was no allowance for credit losses for held to maturity debt securities at September 30, 2023 and 2022. ​ Available for sale debt securities in unrealized loss positions are evaluated for impairment on a quarterly basis. The Company has evaluated available for sale securities that are in an unrealized loss position and has determined that the declines in fair value are attributable to market volatility, not credit quality or other factors. Management recognized no impairment during the three and nine months ended September 30, 2023 and 2022. There was no allowance for credit losses for available for sale debt securities at September 30, 2023 and 2022. ​ Realized Gains and Losses on Debt Securities Net realized gains are included in noninterest income in the Consolidated Statements of Income as net security gains. There were no realized gains or losses on available for sale securities during the three and nine months ended September 30, 2023 and 2022. There was no realized gain or loss for held for maturity debt securities during the three and nine months ended September 30, 2023 and 2022. Equity Securities Included in this category are Community Reinvestment Act ("CRA") investments and the Company’s current other equity holdings of financial institutions. Equity securities are defined to include (a) preferred, common and other ownership interests in entities including partnerships, joint ventures and limited liability companies and (b) rights to acquire or dispose of ownership interests in entities at fixed or determinable prices. The following is a summary of unrealized and realized gains and losses recognized in net income on equity securities during the three and nine months ended September 30, 2023 and 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ For the nine months ended September 30, (In thousands) 2023 2022 2023 2022 Net unrealized losses occurring during the period on equity securities ​ $ (144) ​ $ (576) ​ $ (853) ​ $ (1,631) Net realized gains recognized during the period on equity securities sold during the period ​ 21 ​ — ​ 243 ​ — Net losses recognized during the reporting period on equity securities still held at the reporting date ​ $ (123) ​ $ (576) ​ $ (610) ​ $ (1,631) ​ ​

Loans

Loans	9 Months Ended
	Sep. 30, 2023
Loans
Loans	NOTE 7. Loans The following table sets forth the classification of loans by class, including unearned fees, deferred costs and excluding the allowance for loan losses as of September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ (In thousands) September 30, 2023 December 31, 2022 SBA loans held for investment ​ $ 40,873 ​ $ 38,468 SBA PPP loans ​ ​ 2,507 ​ ​ 5,908 Commercial loans ​ ​ ​ SBA 504 loans ​ 31,808 ​ 35,077 Commercial other ​ 130,967 ​ 117,566 Commercial real estate ​ 968,801 ​ 903,126 Commercial real estate construction ​ 144,580 ​ 131,774 Residential mortgage loans ​ 628,628 ​ 605,091 Consumer loans ​ ​ ​ ​ Home equity ​ 65,461 ​ 68,310 Consumer other ​ ​ 6,728 ​ ​ 9,854 Residential construction loans ​ ​ 133,450 ​ ​ 163,457 Total loans held for investment ​ $ 2,153,803 ​ $ 2,078,631 SBA loans held for sale ​ 19,387 ​ 27,928 Total loans ​ $ 2,173,190 ​ $ 2,106,559 ​ Loans held for investment are stated at the unpaid principal balance, net of unearned discounts and deferred loan origination fees and costs. In accordance with the level yield method, loan origination fees, net of direct loan origination costs, are deferred and recognized over the estimated life of the related loans as an adjustment to the loan yield. Interest is credited to operations primarily based upon the principal balance outstanding. Loans are reported as past due when either interest or principal is unpaid in the following circumstances: fixed payment loans when the borrower is in arrears for two or more monthly payments; open end credit for two or more billing cycles; and single payment notes if interest or principal remains unpaid for 30 days or more. Loans are charged off when collection is sufficiently questionable and when the Company can no longer justify maintaining the loan as an asset on the balance sheet. Loans qualify for charge-off when, after thorough analysis, all possible sources of repayment are insufficient. These include: 1) potential future cash flows, 2) value of collateral and/or 3) strength of co-makers and guarantors. All unsecured loans are charged off upon the establishment of the loan’s nonaccrual status. Additionally, all loans classified as a loss or that portion of the loan classified as a loss is charged off. Loans are made to individuals as well as commercial entities. Specific loan terms vary as to interest rate, repayment and collateral requirements based on the type of loan requested and the credit worthiness of the prospective borrower. Credit risk tends to be geographically concentrated in that a majority of the loan customers are located in the markets serviced by the Bank. Loan performance may be adversely affected by factors impacting the general economy or conditions specific to the real estate market such as geographic location and/or property type. A description of the Company’s different loan segments follows: Small Business Administration (“SBA”) Loans: Loans held for sale represent the guaranteed portion of SBA loans and are reflected at the lower of aggregate cost or market value. When sales of SBA loans do occur, the premium received on the sale and the present value of future cash flows of the servicing assets are recognized in income. All criteria for sale accounting must be met in order for the loan sales to occur. Servicing assets represent the estimated fair value of retained servicing rights, net of servicing costs, at the time loans are sold. Servicing assets are amortized in proportion to, and over the period of, estimated net servicing revenues. Impairment is evaluated based on stratifying the underlying financial assets by date of origination and term. Fair value is determined using prices for similar assets with similar characteristics, when available, or based upon discounted cash flows using market-based assumptions. Serviced loans sold to others are not included in the accompanying Consolidated Balance Sheets. Income and fees collected for loan servicing are credited to noninterest income when earned, net of amortization on the related servicing assets. Commercial Loans: Residential Mortgage, Consumer and Residential Construction Loans: Inherent in the lending function is credit risk, which is the possibility a borrower may not perform in accordance with the contractual terms of their loan. A borrower’s inability to pay their obligations according to the contractual terms can create the risk of past due loans and, ultimately, credit losses, especially on collateral deficient loans. The Company minimizes its credit risk by loan diversification and adhering to credit administration policies and procedures. Due diligence on loans begins when the Company initiates contact regarding a loan with a borrower. Documentation, including a borrower’s credit history, materials establishing the value and liquidity of potential collateral, the purpose of the loan, the source of funds for repayment of the loan and other factors, are analyzed before a loan is submitted for approval. The commercial loan portfolio is then subject to on-going internal reviews for credit quality which in part is derived from ongoing collection and review of borrowers’ financial information, as well as independent credit reviews by an outside firm. The Company’s extension of credit is governed by the Credit Risk Policy which was established to control the quality of the Company’s loans. This policy and the underlying procedures are reviewed and approved by the Board of Directors on a regular basis. Credit Ratings The Company places all SBA and commercial loans into various credit risk rating categories based on an assessment of the expected ability of the borrowers to properly service their debt. The assessment considers numerous factors including, but not limited to, current financial information on the borrower, historical payment experience, strength of any guarantor, nature of and value of any collateral, acceptability of the loan structure and documentation, relevant public information and current economic trends. This credit risk rating analysis is performed when the loan is initially underwritten and then annually based on set criteria in the loan policy. The Company uses the following regulatory definitions for criticized and classified risk ratings: Pass: Special Mention: Substandard: Loss: These loans have all the weaknesses inherent in those classified as substandard, with the added characteristic that the weaknesses make collection or liquidation in full highly questionable and improbable, based on currently existing facts, conditions and values. Once a borrower is deemed incapable of repayment of unsecured debt, the loan is termed a “Loss” and charged off immediately. For residential mortgage, consumer and residential construction loans, management uses performing versus nonperforming as the best indicator of credit quality. Nonperforming loans consist of loans that are not accruing interest (nonaccrual loans) as a result of principal or interest being in default for a period of 90 days or more or when the ability to collect principal and interest according to the contractual terms is in doubt. These credit quality indicators are updated on an ongoing basis, as a loan is placed on nonaccrual status as soon as management believes there is sufficient doubt as to the ultimate ability to collect interest on a loan. At September 30, 2023, the Company owned $0.3 million in commercial properties that were included in Prepaid expenses and other assets in the Consolidated Balance Sheets, compared to none at December 31, 2022. Additionally, there were $12.5 million in loans in the process of foreclosure at September 30, 2023, compared to $2.1 million at December 31, 2022. At September 30, 2023, foreclosures in process included loans in the Commercial, SBA, Residential mortgage, Residential construction and Home equity categories. Nonaccrual and Past Due Loans Nonaccrual loans consist of loans that are not accruing interest as a result of principal or interest being in default for a period of 90 days or more or when the ability to collect principal and interest according to the contractual terms is in doubt. When a loan is classified as nonaccrual, interest accruals are discontinued and all past due interest previously recognized as income is reversed and charged against current period earnings. Generally, until the loan becomes current, any payments received from the borrower are applied to outstanding principal until such time as management determines that the financial condition of the borrower and other factors merit recognition of a portion of such payments as interest income. Loans may be returned to an accrual status when the ability to collect is reasonably assured and when the loan is brought current as to principal and interest. The risk of loss is difficult to quantify and is subject to fluctuations in collateral values, general economic conditions and other factors. The Company values its collateral through the use of appraisals, broker price opinions and knowledge of its local market. The following tables set forth an aging analysis of past due and nonaccrual loans as of September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2023 ​ ​ ​ ​ ​ 90+ days ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 30 ‑ 59 days ​ 60 ‑ 89 days ​ and still ​ ​ ​ Total past ​ ​ ​ ​ ​ ​ (In thousands) ​ past due ​ past due ​ accruing ​ Nonaccrual ​ due ​ Current ​ Total loans SBA loans held for investment ​ $ 4,083 ​ $ 420 ​ $ — ​ $ 3,445 ​ $ 7,948 ​ $ 32,925 ​ $ 40,873 Commercial loans ​ ​ ​ ​ ​ ​ ​ ​ SBA 504 loans ​ — ​ — ​ — ​ — ​ — ​ 31,808 ​ 31,808 Commercial other ​ — ​ — ​ — ​ 668 ​ 668 ​ 130,299 ​ 130,967 Commercial real estate ​ 553 ​ — ​ — ​ 82 ​ 635 ​ 968,166 ​ 968,801 Commercial real estate construction ​ — ​ — ​ — ​ — ​ — ​ 144,580 ​ 144,580 Residential mortgage loans ​ 4,961 ​ 3,347 ​ 260 ​ 10,270 ​ 18,838 ​ 609,790 ​ 628,628 Consumer loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Home equity ​ 286 ​ 15 ​ — ​ 125 ​ 426 ​ 65,035 ​ 65,461 Consumer other ​ ​ 1,319 ​ ​ 52 ​ ​ 5 ​ ​ — ​ ​ 1,376 ​ ​ 5,352 ​ ​ 6,728 Residential construction loans ​ ​ — ​ ​ — ​ ​ — ​ ​ 3,201 ​ ​ 3,201 ​ ​ 130,249 ​ ​ 133,450 Total loans held for investment, excluding SBA PPP ​ ​ 11,202 ​ ​ 3,834 ​ ​ 265 ​ ​ 17,791 ​ ​ 33,092 ​ ​ 2,118,204 ​ ​ 2,151,296 SBA loans held for sale ​ 815 ​ — ​ — ​ — ​ 815 ​ 18,572 ​ 19,387 Total loans, excluding SBA PPP ​ $ 12,017 ​ $ 3,834 ​ $ 265 ​ $ 17,791 ​ $ 33,907 ​ $ 2,136,776 ​ $ 2,170,683 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 ​ ​ ​ ​ ​ 90+ days ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 30 ‑ 59 days ​ 60 ‑ 89 days ​ and still ​ ​ ​ Total past ​ ​ ​ ​ ​ ​ (In thousands) ​ past due ​ past due ​ accruing ​ Nonaccrual ​ due ​ Current ​ Total loans SBA loans held for investment ​ $ — ​ $ 576 ​ $ — ​ $ 690 ​ $ 1,266 ​ $ 37,202 ​ $ 38,468 Commercial loans ​ ​ ​ ​ ​ ​ ​ SBA 504 loans ​ — ​ — ​ — ​ — ​ — ​ 35,077 ​ 35,077 Commercial other ​ 198 ​ 300 ​ — ​ 777 ​ 1,275 ​ 116,291 ​ 117,566 Commercial real estate ​ 22 ​ 188 ​ — ​ 805 ​ 1,015 ​ 902,111 ​ 903,126 Commercial real estate construction ​ — ​ — ​ — ​ — ​ — ​ 131,774 ​ 131,774 Residential mortgage loans ​ — ​ 982 ​ — ​ 3,361 ​ 4,343 ​ 600,748 ​ 605,091 Consumer loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Home equity ​ — ​ — ​ — ​ — ​ — ​ 68,310 ​ 68,310 Consumer other ​ ​ 18 ​ 7 ​ — ​ — ​ 25 ​ 9,829 ​ 9,854 Residential construction loans ​ ​ — ​ ​ — ​ ​ — ​ ​ 3,432 ​ ​ 3,432 ​ ​ 160,025 ​ ​ 163,457 Total loans held for investment, excluding SBA PPP ​ ​ 238 ​ ​ 2,053 ​ ​ — ​ ​ 9,065 ​ ​ 11,356 ​ ​ 2,061,367 ​ ​ 2,072,723 SBA loans held for sale ​ 2,195 ​ — ​ — ​ — ​ 2,195 ​ 25,733 ​ 27,928 Total loans, excluding SBA PPP ​ $ 2,433 ​ $ 2,053 ​ $ — ​ $ 9,065 ​ $ 13,551 ​ $ 2,087,100 ​ $ 2,100,651 ​ The Company is using the practical expedient The following table shows the internal loan classification risk by loan portfolio classification by origination year as of September 30, 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Term Loans ​ ​ ​ ​ ​ ​ ​ Amortized Cost Basis by Origination Year ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ (In thousands) ​ ​ 2023 ​ ​ 2022 ​ ​ 2021 ​ ​ 2020 ​ ​ 2019 ​ ​ 2018 and Earlier ​ ​ Revolving Loans Amortized Cost Basis ​ ​ Total SBA loans held for investment ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Risk Rating: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Pass ​ $ 1,057 ​ $ 7,113 ​ $ 5,151 ​ $ 6,131 ​ $ 2,669 ​ $ 11,334 ​ $ - ​ $ 33,455 Special Mention ​ ​ - ​ ​ 1,797 ​ ​ - ​ ​ 510 ​ ​ - ​ ​ 778 ​ ​ - ​ ​ 3,085 Substandard ​ ​ - ​ ​ 1,256 ​ ​ 2,225 ​ ​ 190 ​ ​ - ​ ​ 662 ​ ​ - ​ ​ 4,333 Total SBA loans held for investment ​ $ 1,057 ​ $ 10,166 ​ $ 7,376 ​ $ 6,831 ​ $ 2,669 ​ $ 12,774 ​ $ - ​ $ 40,873 SBA loans held for investment ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Current-period gross writeoffs ​ $ - ​ $ 100 ​ $ - ​ $ - ​ $ 113 ​ $ - ​ $ - ​ $ 213 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ SBA PPP loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Risk Rating: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Pass ​ $ - ​ $ - ​ $ 2,507 ​ $ - ​ $ - ​ $ - ​ $ - ​ $ 2,507 Special Mention ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - Substandard ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - Total SBA PPP loans ​ $ - ​ $ - ​ $ 2,507 ​ $ - ​ $ - ​ $ - ​ $ - ​ $ 2,507 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Commercial loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Risk Rating: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Pass ​ $ 101,748 ​ $ 358,414 ​ $ 186,930 ​ $ 136,850 ​ $ 102,312 ​ $ 278,861 ​ $ 95,372 ​ $ 1,260,487 Special Mention ​ ​ - ​ ​ 82 ​ ​ 212 ​ ​ - ​ ​ 1,727 ​ ​ 10,307 ​ ​ 645 ​ ​ 12,973 Substandard ​ ​ - ​ ​ - ​ ​ - ​ ​ 236 ​ ​ - ​ ​ 2,460 ​ ​ - ​ ​ 2,696 Total commercial loans ​ $ 101,748 ​ $ 358,496 ​ $ 187,142 ​ $ 137,086 ​ $ 104,039 ​ $ 291,628 ​ $ 96,017 ​ $ 1,276,156 Commercial loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Current-period gross writeoffs ​ $ - ​ $ - ​ $ 150 ​ $ - ​ $ 350 ​ $ - ​ $ - ​ $ 500 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential mortgage loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Risk Rating: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Performing ​ $ 83,675 ​ $ 259,430 ​ $ 73,961 ​ $ 52,432 ​ $ 32,944 ​ $ 115,498 ​ $ - ​ $ 617,940 Nonperforming ​ ​ 5,032 ​ ​ 2,174 ​ ​ 550 ​ ​ 1,055 ​ ​ 276 ​ ​ 1,601 ​ ​ - ​ ​ 10,688 Total residential mortgage loans ​ $ 88,707 ​ $ 261,604 ​ $ 74,511 ​ $ 53,487 ​ $ 33,220 ​ $ 117,099 ​ $ - ​ $ 628,628 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Consumer loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Risk Rating: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Performing ​ $ 3,041 ​ $ 5,103 ​ $ 4,450 ​ $ 696 ​ $ 2,589 ​ $ 8,045 ​ $ 47,875 ​ $ 71,799 Nonperforming ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ 390 ​ ​ 390 Total consumer loans ​ $ 3,041 ​ $ 5,103 ​ $ 4,450 ​ $ 696 ​ $ 2,589 ​ $ 8,045 ​ $ 48,265 ​ $ 72,189 Consumer loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Current-period gross writeoffs ​ $ - ​ $ - ​ $ 397 ​ $ - ​ $ - ​ $ - ​ $ - ​ $ 397 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential construction ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Risk Rating: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Performing ​ $ 20,697 ​ $ 72,544 ​ $ 34,165 ​ $ 1,550 ​ $ 500 ​ $ 732 ​ $ - ​ $ 130,188 Nonperforming ​ ​ - ​ ​ - ​ ​ 377 ​ ​ 547 ​ ​ - ​ ​ 1,303 ​ ​ 1,035 ​ ​ 3,262 Total residential construction loans ​ $ 20,697 ​ $ 72,544 ​ $ 34,542 ​ $ 2,097 ​ $ 500 ​ $ 2,035 ​ $ 1,035 ​ $ 133,450 Residential construction ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Current-period gross writeoffs ​ $ - ​ $ - ​ $ - ​ $ - ​ $ - ​ $ 500 ​ $ 400 ​ $ 900 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total loans held for investment ​ $ 215,250 ​ $ 707,913 ​ $ 310,528 ​ $ 200,197 ​ $ 143,017 ​ $ 431,581 ​ $ 145,317 ​ $ 2,153,803 ​ ​ The tables below detail the Company’s loan portfolio by class according to their credit quality indicators discussed in the paragraphs above as of December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 ​ ​ SBA & Commercial loans - Internal risk ratings (In thousands) Pass Special mention Substandard Total SBA loans held for investment ​ $ 37,163 ​ $ 558 ​ $ 747 ​ $ 38,468 SBA PPP loans ​ ​ 5,908 ​ ​ — ​ ​ — ​ ​ 5,908 Commercial loans ​ ​ ​ ​ SBA 504 loans ​ 35,077 ​ — ​ — ​ 35,077 Commercial other ​ 110,107 ​ 6,220 ​ 1,239 ​ 117,566 Commercial real estate ​ 894,110 ​ 6,228 ​ 2,788 ​ 903,126 Commercial real estate construction ​ 131,774 ​ — ​ — ​ 131,774 Total commercial loans ​ 1,171,068 ​ 12,448 ​ 4,027 ​ 1,187,543 Total SBA and commercial loans ​ $ 1,214,139 ​ $ 13,006 ​ $ 4,774 ​ $ 1,231,919 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential mortgage, Consumer & Residential construction loans - Performing/Nonperforming (In thousands) ​ ​ Performing ​ Nonperforming ​ Total Residential mortgage loans ​ ​ $ 601,730 ​ $ 3,361 ​ $ 605,091 Consumer loans ​ ​ ​ ​ ​ Home equity ​ ​ 68,310 ​ — ​ 68,310 Consumer other ​ ​ ​ ​ ​ 9,854 ​ — ​ 9,854 Total consumer loans ​ ​ ​ ​ ​ 78,164 ​ — ​ 78,164 Residential construction loans ​ ​ ​ ​ ​ 160,025 ​ ​ 3,432 ​ ​ 163,457 Total residential mortgage, consumer and residential construction loans ​ ​ $ 839,919 ​ $ 6,793 ​ $ 846,712 ​ Modifications The allowance for credit losses incorporates an estimate of lifetime expected credit losses and is recorded on each asset upon asset origination or acquisition. The starting point for the estimate of the allowance for credit Because the effect of most modifications made to borrowers experiencing financial difficulty is already included in the allowance for credit losses because of the measurement methodologies used to estimate the allowance, a change to the allowance for credit losses is generally not recorded upon modification. Occasionally, the Company modifies loans by providing principal forgiveness on certain of its real estate loans. When principal forgiveness is provided, the amortized cost basis of the asset is written off against the allowance for credit losses. The amount of the principal forgiveness is deemed to be uncollectible; therefore, that portion of the loan is written off, resulting in a reduction of the amortized cost basis and a corresponding adjustment to the allowance for credit losses. In some cases, the Company will modify a certain loan by providing multiple types of concessions. Typically, one type of concession, such as a term extension, is granted initially. If the borrower continues to experience financial difficulty, another concession, such as principal forgiveness, may be granted. The following table shows the amortized cost basis at the end of the reporting period of the loans modified to borrowers experiencing financial difficulty, disaggregated by class of gross loans and type of concession granted (numbers in thousands) during the nine months ended September 30, 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Term Extension ​ ​ ​ Amortized Cost Basis ​ % of Total Class of ​ ​ ​ ​ September 30, 2023 ​ Gross Loans ​ Commercial ​ $ 952 ​ 0.1 % ​ ​ ​ ​ ​ ​ ​ ​ ​ Principal Forgiveness/Deferment ​ ​ ​ Amortized Cost Basis ​ % of Total Class of ​ ​ ​ ​ September 30, 2023 ​ Gross Loans ​ SBA ​ $ 9 ​ 0.0 % ​ Modifications for the year made to borrowers experiencing financial difficulty added a weighted average of 7.7 years to the life of the modified loans, which reduced monthly payment amounts for the borrowers. Upon the Company's determination that a modified loan (or portion of a loan) has subsequently been deemed uncollectible, the loan (or portion of the loan) is written off. Therefore, the amortized cost basis of the loan is reduced by the uncollectible amount and the allowance for credit losses is adjusted by the same amount. No loans that were modified during the three and nine months ended September 30, 2023 had a payment default during the period and all loans were current as of September 30, 2023. ​ ​ ​ ​ ​ ​ ​

Allowance for Credit Losses and

Allowance for Credit Losses and Reserve for Unfunded Loan Commitments	9 Months Ended
	Sep. 30, 2023
Allowance for Credit Losses and Reserve for Unfunded Loan Commitments
Allowance for Credit Losses and Reserve for Unfunded Loan Commitments	NOTE 8. Allowance for Credit Losses and Reserve for Unfunded Loan Commitments Allowance for Credit Losses The Company has an established methodology to determine the adequacy of the allowance for credit losses that assesses the risks and losses inherent in the loan portfolio. At a minimum, the adequacy of the allowance for credit losses is reviewed by management on a quarterly basis. The standardized methodology used to assess the adequacy of the allowance includes the allocation of specific and general reserves. The same standard methodology is used, regardless of loan type. Specific reserves are evaluated for individually evaluated loans. The general reserve is set based upon a representative average historical net charge-off rate adjusted for the following environmental factors: delinquency and impairment trends, charge-off and recovery trends, volume and loan term trends, changes in risk and underwriting policy trends, staffing and experience changes, national and local economic trends, industry conditions and credit concentration changes. Within the historical net charge-off rate, the Company weights the data dating back to 2015 on a straight line basis and projects the losses on a weighted average remaining maturity basis for each segment. All of the environmental factors are ranked and assigned a basis points value based on the following scale: low, low moderate, moderate, high moderate and high risk. Each environmental factor is evaluated separately for each class of loans and risk weighted based on its individual characteristics. ● For SBA and commercial loans, the estimate of loss based on pools of loans with similar characteristics is made through the use of a standardized loan grading system that is applied on an individual loan level and updated on a continuous basis. The loan grading system incorporates reviews of the financial performance of the borrower, including cash flow, debt-service coverage ratio, earnings power, debt level and equity position, in conjunction with an assessment of the borrower’s industry and future prospects. It also incorporates analysis of the type of collateral and the relative loan to value ratio. ● For residential mortgage, consumer and residential construction loans, the estimate of loss is based on pools of loans with similar characteristics. Factors such as credit score, delinquency status and type of collateral are evaluated. Factors are updated frequently to capture the recent behavioral characteristics of the subject portfolios, as well as any changes in loss mitigation or credit origination strategies, and adjustments to the reserve factors are made as needed. According to the Company’s policy, a loss (“charge-off”) is to be recognized and charged to the allowance for credit losses as soon as a loan is recognized as uncollectable. All credits which are 90 days past due must be analyzed for the Company’s ability to collect on the credit. Once a loss is known to exist, the charge-off approval process is immediately expedited. This charge-off policy is followed for all loan types. The following tables detail the activity in the allowance for credit losses by portfolio segment for the three and nine months ended September 30, 2023 and 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, 2023 ​ ​ ​ SBA ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential ​ ​ ​ (In thousands) ​ Held for Investment ​ Commercial ​ Residential ​ Consumer ​ construction ​ Total Balance, beginning of period ​ $ 1,556 ​ $ 15,516 ​ $ 6,437 ​ $ 845 ​ $ 1,634 ​ $ 25,988 Charge-offs ​ (100) ​ (500) ​ — ​ (52) ​ — ​ (652) Recoveries ​ 1 ​ 10 ​ — ​ 37 ​ — ​ 48 Net (charge-offs) recoveries ​ (99) ​ (490) ​ — ​ (15) ​ — ​ (604) Provision for (credit to) credit losses charged to expense ​ 199 ​ 325 ​ (6) ​ 130 ​ (114) ​ 534 Balance, end of period ​ $ 1,656 ​ $ 15,351 ​ $ 6,431 ​ $ 960 ​ $ 1,520 ​ $ 25,918 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential ​ ​ ​ (In thousands) ​ SBA ​ Commercial ​ Residential ​ Consumer ​ construction ​ Total Balance, beginning of period ​ $ 758 ​ $ 14,908 ​ $ 4,786 ​ $ 803 ​ $ 1,603 ​ $ 22,858 Charge-offs ​ — ​ (501) ​ — ​ (50) ​ — ​ (551) Recoveries ​ 5 ​ 23 ​ — ​ 9 ​ — ​ 37 Net recoveries (charge-offs) ​ 5 ​ (478) ​ — ​ (41) ​ — ​ (514) Provision for (credit to) credit losses charged to expense ​ 68 ​ 803 ​ 449 ​ 349 ​ (152) ​ 1,517 Balance, end of period ​ $ 831 ​ $ 15,233 ​ $ 5,235 ​ $ 1,111 ​ $ 1,451 ​ $ 23,861 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the nine months ended September 30, 2023 ​ ​ ​ SBA ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential ​ ​ ​ (In thousands) ​ Held for Investment ​ Commercial ​ Residential ​ Consumer ​ construction ​ Total Balance, beginning of period ​ $ 875 ​ $ 15,254 ​ $ 5,450 ​ $ 990 ​ $ 2,627 ​ $ 25,196 Effect of adopting Accounting Standards Update ("ASU") No. 2016-13 ("CECL") ​ ​ 163 ​ ​ 171 ​ ​ 376 ​ ​ 101 ​ ​ 36 ​ ​ 847 Charge-offs ​ (213) ​ (500) ​ — ​ (397) ​ (900) ​ (2,010) Recoveries ​ 16 ​ 377 ​ — ​ 73 ​ — ​ 466 Net (charge-offs) recoveries ​ (197) ​ (123) ​ — ​ (324) ​ (900) ​ (1,544) Provision for (credit to) loan losses charged to expense ​ 815 ​ 49 ​ 605 ​ 193 ​ (243) ​ 1,419 Balance, end of period ​ $ 1,656 ​ $ 15,351 ​ $ 6,431 ​ $ 960 ​ $ 1,520 ​ $ 25,918 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the nine months ended September 30, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential ​ ​ ​ (In thousands) ​ SBA ​ Commercial ​ Residential ​ Consumer ​ construction ​ Total Balance, beginning of period ​ $ 1,074 ​ $ 15,053 ​ $ 4,114 ​ $ 671 ​ $ 1,390 ​ $ 22,302 Charge-offs ​ — ​ (1,001) ​ — ​ (96) ​ — ​ (1,097) Recoveries ​ 33 ​ 83 ​ 1 ​ 13 ​ — ​ 130 Net (charge-offs) recoveries ​ 33 ​ (918) ​ 1 ​ (83) ​ — ​ (967) Provision (credit) for loan losses charged to expense ​ (276) ​ 1,098 ​ 1,120 ​ 523 ​ 61 ​ 2,526 Balance, end of period ​ $ 831 ​ $ 15,233 ​ $ 5,235 ​ $ 1,111 ​ $ 1,451 ​ $ 23,861 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ The following tables present loans and their related allowance for credit losses, by portfolio segment, as of September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2023 ​ ​ ​ SBA ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential ​ ​ ​ (In thousands) ​ Held for Investment ​ Commercial ​ Residential ​ Consumer ​ construction ​ Total Allowance for credit losses ending balance: ​ ​ ​ ​ ​ ​ Individually evaluated ​ $ 619 ​ $ 369 ​ $ 386 ​ $ — ​ $ 285 ​ $ 1,659 Collectively evaluated ​ 1,037 ​ 14,982 ​ 6,045 ​ 960 ​ 1,235 ​ 24,259 Total ​ $ 1,656 ​ $ 15,351 ​ $ 6,431 ​ $ 960 ​ $ 1,520 ​ $ 25,918 Loan ending balances: ​ ​ ​ ​ ​ ​ Individually evaluated ​ $ 256 ​ $ 750 ​ $ 11,059 ​ $ 131 ​ $ 3,201 ​ $ 15,397 Collectively evaluated ​ 40,617 ​ 1,275,406 ​ 617,569 ​ 72,058 ​ 130,249 ​ 2,135,899 Total ​ $ 40,873 ​ $ 1,276,156 ​ $ 628,628 ​ $ 72,189 ​ $ 133,450 ​ $ 2,151,296 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential ​ ​ ​ (In thousands) ​ SBA ​ Commercial ​ Residential ​ Consumer ​ construction ​ Total Allowance for credit losses ending balance: ​ ​ ​ ​ ​ ​ ​ Individually evaluated for impairment ​ $ 115 ​ $ 516 ​ $ 36 ​ $ — ​ $ 1,112 ​ $ 1,779 Collectively evaluated for impairment ​ 760 ​ 14,738 ​ 5,414 ​ 990 ​ 1,515 ​ 23,417 Total ​ $ 875 ​ $ 15,254 ​ $ 5,450 ​ $ 990 ​ $ 2,627 ​ $ 25,196 Loan ending balances: ​ ​ ​ ​ ​ ​ ​ Individually evaluated for impairment ​ $ 690 ​ $ 3,101 ​ $ 3,361 ​ $ — ​ $ 3,432 ​ $ 10,584 Collectively evaluated for impairment ​ 71,614 ​ 1,184,442 ​ 601,730 ​ 78,164 ​ 160,025 ​ 2,095,975 Total ​ $ 72,304 ​ $ 1,187,543 ​ $ 605,091 ​ $ 78,164 ​ $ 163,457 ​ $ 2,106,559 ​ Reserve for Unfunded Loan Commitments In addition to the allowance for credit losses, the Company maintains a reserve for unfunded loan commitments at a level that management believes is adequate to absorb estimated probable losses. At September 30, 2023 and December 31, 2022, a $ 0.5 million commitment reserve was reported on the balance sheet as “Accrued expenses and other liabilities” and reported on the income statement as “Other expenses”.

Derivative Financial Instrument

Derivative Financial Instruments and Hedging Activities	9 Months Ended
	Sep. 30, 2023
Derivative Financial Instruments and Hedging Activities
Derivative Financial Instruments and Hedging Activities	NOTE 9. Derivative Financial Instruments and Hedging Activities Derivative Financial Instruments The Company has derivative financial instruments in the form of interest rate swap agreements, which derive their value from underlying interest rates. These transactions involve both credit and market risk. The notional amounts are amounts on which calculations, payments and the value of the derivatives are based. Notional amounts do not represent direct credit exposures. Direct credit exposure is limited to the net difference between the calculated amounts to be received and paid, if any. Such difference, which represents the fair value of the derivative instrument, is reflected on the Company’s balance sheet as “Prepaid expenses and other assets” or “Accrued expenses and other liabilities”. The Company is exposed to credit-related losses in the event of nonperformance by the counterparties to any derivative agreement. The Company controls the credit risk of its financial contracts through credit approvals, limits and monitoring procedures and does not expect any counterparties to fail their obligations. The Company deals only with primary dealers. Derivative instruments are generally either negotiated via over the counter (“OTC”) contracts or standardized contracts executed on a recognized exchange. Negotiated OTC derivative contracts are generally entered into between two counterparties that negotiate specific agreement terms, including the underlying instrument, amount, exercise prices and maturity. Risk Management Policies – Hedging Instruments The primary focus of the Company’s asset/liability management program is to monitor the sensitivity of the Company’s net portfolio value and net income under varying interest rate scenarios to take steps to control its risks. On a quarterly basis, the Company evaluates the effectiveness of entering into any derivative agreement by measuring the cost of such an agreement in relation to the reduction in net portfolio value and net income volatility within an assumed range of interest rates. Interest Rate Risk Management – Cash Flow Hedging Instruments The Company has variable rate debt as a source of funds for use in the Company’s lending and investment activities and for other general business purposes. These debt obligations expose the Company to variability in interest payments due to changes in interest rates. If interest rates increase, interest expense increases. Conversely, if interest rates decrease, interest expense decreases. Management believes it is prudent to limit the variability of a portion of its interest payments and, therefore hedges its variable-rate interest payments. To meet this objective, management enters into interest rate swap agreements whereby the Company receives variable interest rate payments and makes fixed interest rate payments during the contract period. A summary of the Company’s outstanding interest rate swap agreements used to hedge variable rate debt at September 30, 2023 and December 31, 2022, respectively is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ (In thousands, except percentages and years) September 30, 2023 December 31, 2022 Notional amount ​ $ 20,000 ​ $ 20,000 ​ Fair value ​ $ 1,264 ​ $ 1,537 ​ Weighted average pay rate ​ 0.83 % 0.83 % Weighted average receive rate ​ 5.56 % 1.50 % Weighted average maturity in years ​ 1.44 ​ 2.57 ​ Number of contracts ​ 1 ​ 1 ​ ​ During the three and nine months ended September 30, 2023, the Company received variable rate Secured Overnight Financing Rate ("SOFR") payments from and paid fixed rates in accordance with its interest rate swap agreements. At September 30, 2023, the unrealized gain relating to interest rate swaps was recorded as a derivative asset and is included in “Prepaid expenses and other assets” on the Company’s Balance Sheet. Changes in the fair value of the interest rate swaps designated as hedging instruments of the variability of cash flows associated with long-term debt are reported in other comprehensive income. The following table presents the net gains and losses recorded in other comprehensive income and the consolidated financial statements relating to the cash flow derivative instruments at September 30, 2023 and 2022, respectively: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ For the nine months ended September 30, ​ (In thousands) 2023 2022 ​ 2023 2022 ​ (Loss) Gain recognized in OCI ​ $ (139) $ 452 ​ $ (273) ​ $ 1,386 ​ Gain reclassified from AOCI into net income $ 238 $ — ​ $ 656 $ — ​ ​

Employee Benefit Plans

Employee Benefit Plans	9 Months Ended
	Sep. 30, 2023
Employee Benefit Plans
Employee Benefit Plans	NOTE 10. Employee Benefit Plans Stock Option Plans The Company has maintained option plans and maintains an equity incentive plan, which allow for the grant of options to officers, employees and members of the Board of Directors. Grants of options under the Company’s plans generally vest over 3 years and must be exercised within 10 years of the date of grant. Transactions under the Company’s plans for the nine months ended September 30, 2023 are summarized in the following table: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ Weighted ​ average ​ ​ ​ ​ ​ ​ ​ average ​ remaining ​ Aggregate ​ ​ ​ ​ exercise ​ contractual ​ intrinsic ​ ​ Shares ​ price ​ life in years ​ value Outstanding at December 31, 2022 559,499 ​ $ 18.09 5.9 ​ $ 5,168,740 Options granted — ​ ​ ​ Options exercised (73,184) 19.04 ​ Options forfeited (1,332) ​ 18.64 ​ Options expired — ​ ​ ​ Outstanding at September 30, 2023 484,983 ​ $ 17.95 5.2 ​ $ 2,659,163 Exercisable at September 30, 2023 ​ 445,825 ​ $ 17.85 5.0 ​ $ 2,488,426 ​ ​ On May 5, 2023, the Company adopted the 2023 Equity Compensation Plan providing for grants of up to 500,000 shares to be allocated between incentive and non-qualified stock options, restricted stock awards, performance units and deferred stock. The Plan, along with the 2019 Equity Compensation Plan adopted on April 25, 2019, replaced all previously approved and established equity plans then currently in effect. As of September 30, 2023, 281,500 options and 267,900 shares of restricted stock have been awarded from the plans. In addition, 16,828 unvested options and 16,999 unvested shares of restricted stock were cancelled and returned to the plans leaving 484,427 shares available for future grants. The fair values of the options granted are estimated on the date of grant using the Black-Scholes option-pricing model. There were no options granted during the nine months ended September 30, 2023 or 2022. ​ Upon exercise, the Company issues shares from its authorized but unissued common stock to satisfy the options. The following table presents information about options exercised during the three and nine months ended September 30, 2023 and 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ For the nine months ended September 30, ​ ​ 2023 2022 2023 2022 ​ Number of options exercised ​ 22,249 ​ ​ 23,168 ​ 73,184 85,877 ​ Total intrinsic value of options exercised ​ $ 164,978 ​ ​ 215,476 ​ $ 480,981 $ 1,081,833 ​ Cash received from options exercised ​ $ 394,665 ​ ​ 441,272 ​ 1,393,551 1,394,809 ​ Tax deduction realized from options ​ $ 49,634 ​ ​ 64,826 ​ 144,703 325,469 ​ ​ The following table summarizes information about stock options outstanding and exercisable at September 30, 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Options outstanding ​ Options exercisable ​ ​ ​ Weighted average Weighted ​ Weighted ​ ​ Options ​ remaining contractual ​ average ​ Options ​ average Range of exercise prices ​ outstanding ​ life (in years) ​ exercise price ​ exercisable ​ exercise price $7.25 - 16.51 128,873 3.4 ​ $ 12.01 128,873 ​ $ 12.01 16.52 - 19.26 120,499 6.0 ​ 18.03 97,674 ​ 18.04 19.27 - 20.88 ​ 127,411 ​ 5.9 ​ ​ 20.33 ​ 111,078 ​ ​ 20.30 20.89 - 22.57 108,200 5.8 ​ 22.11 108,200 ​ 22.11 Total 484,983 5.2 ​ $ 17.95 445,825 ​ $ 17.85 ​ Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") Topic 718, “Compensation - Stock Compensation,” ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ For the nine months ended September 30, ​ (In thousands) 2023 2022 ​ 2023 2022 ​ Compensation expense ​ $ 72 ​ $ 129 ​ $ 236 ​ $ 431 ​ Income tax benefit ​ $ 21 ​ $ 37 ​ $ 68 ​ $ 125 ​ ​ As of September 30, 2023, unrecognized compensation costs related to nonvested share-based stock option compensation arrangements granted under the Company’s plans totaled approximately $104 thousand. That cost is expected to be recognized over a weighted average period of 0.4 years. Restricted Stock Awards Restricted stock is issued under the Company’s active Equity Compensation Plans to reward employees and directors and to retain them by distributing stock over a period of time. Restricted stock awards granted to date generally vest over a period of 4 years and are recognized as compensation to the recipient over the vesting period. The awards are recorded at fair market value at the time of grant and amortized into salary expense on a straight line basis over the vesting period. The following table summarizes nonvested restricted stock activity for the nine months ended September 30, 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ Average grant ​ ​ Shares ​ date fair value Nonvested restricted stock at December 31, 2022 164,570 ​ $ 24.77 Granted 58,500 ​ ​ 22.93 Cancelled (4,599) ​ ​ 26.37 Vested (41,973) ​ ​ 23.13 Nonvested restricted stock at September 30, 2023 176,498 ​ $ 24.51 ​ ​ Restricted stock awards granted during the three and nine months ended September 30, 2023 and 2022 were as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ For the nine months ended September 30, ​ 2023 2022 ​ 2023 2022 Number of shares granted ​ 3,000 ​ 2,000 ​ ​ 58,500 ​ 73,000 Average grant date fair value ​ $ 25.24 ​ $ 27.89 ​ $ 22.93 ​ $ 27.54 ​ Compensation expense related to restricted stock for the three and nine months ended September 30, 2023 and 2022 is detailed in the following table: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ For the nine months ended September 30, ​ (In thousands) 2023 2022 ​ 2023 2022 ​ Compensation expense ​ $ 357 ​ $ 276 ​ $ 1,033 ​ $ 808 ​ Income tax benefit ​ $ 103 ​ $ 80 ​ $ 298 ​ $ 234 ​ ​ As of September 30, 2023, there was approximately $3.5 million of unrecognized compensation cost related to nonvested restricted stock awards granted under the Company’s equity plans. That cost is expected to be recognized over a weighted average period of 2.7 years.

Regulatory Capital

Regulatory Capital	9 Months Ended
	Sep. 30, 2023
Regulatory Capital
Regulatory Capital	NOTE 11. Regulatory Capital Under the Economic Growth, Regulatory Relief and Consumer Protection Act, the Bank is considered a qualifying community banking organization, which allows the Bank to elect to opt into the community bank leverage ratio (“CBLR”) in its regulatory filings. The Bank has opted into the CBLR, and is therefore not required to comply with the Basel III capital requirements. The following table shows the CBLR ratio for the Company and the Bank as of September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ At September 30, 2023 ​ ​ At December 31, 2022 ​ ​ Company Bank Company Bank CBLR 10.76 % 10.35 % 10.88 % 10.34 % ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2023
Subsequent Events
Subsequent Events	​ ​ NOTE 12. Subsequent Events The Company has evaluated all events or transactions that occurred through the date the Company issued these financial statements. ​

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Significant Accounting Policies
Overview	The accompanying Consolidated Financial Statements include the accounts of Unity Bancorp, Inc. (the "Parent Company") and its wholly-owned subsidiary, Unity Bank (the "Bank" or when consolidated with the Parent Company, the "Company"). The Bank has multiple subsidiaries used to hold part of its investment and loan portfolios. All significant intercompany balances and transactions have been eliminated in consolidation. Certain reclassifications have been made to prior period amounts to conform to the current year presentation, with no impact on current earnings or shareholders’ equity. The financial information has been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and has not been audited. In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and revenues and expenses during the reporting periods. Actual results could differ from those estimates. Amounts requiring the use of significant estimates include the allowance for credit losses, valuation of deferred tax and servicing assets, the valuation of securities and the determination of impairment for securities and fair value disclosures. Management believes that the allowance for credit losses is adequate. While management uses available information to recognize credit losses, future additions to the allowance for credit losses may be necessary based on changes in economic conditions and the general credit quality of the loan portfolio. The interim unaudited Consolidated Financial Statements included herein have been prepared in accordance with instructions for Form 10-Q and the rules and regulations of the Securities and Exchange Commission (“SEC”) and consist of normal recurring adjustments, that in the opinion of management, are necessary for the fair presentation of interim results. The results of operations for the nine months ended September 30, 2023 are not necessarily indicative of the results which may be expected for the entire year. As used in this Form 10-Q, “we” and “us” and “our” refer to Unity Bancorp, Inc., and its consolidated subsidiary, Unity Bank, depending on the context. Certain information and financial disclosures required by U.S. GAAP have been condensed or omitted from interim reporting pursuant to SEC rules. Interim financial statements should be read in conjunction with the Company’s Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
Risks and Uncertainties	Risks and Uncertainties Overall, the markets and customers serviced by the Company may be significantly impacted by ongoing macro-economic trends, such as inflation and recessionary pressures created by a higher interest rate environment. The Company assesses the impact of inflation on an ongoing basis. Market conditions and external factors may unpredictably impact the competitive landscape for deposits in the banking industry. Additionally, the rising interest rate environment has increased competition for liquidity and the premium at which liquidity is available to meet funding needs. The Company believes the sources of liquidity presented in the Unaudited Consolidated Financial Statements and the Notes to the Unaudited Consolidated Financial Statements are sufficient to meet its needs as of the balance sheet date. An unexpected influx of withdrawals of deposits could adversely impact the Company's ability to rely on organic deposits to primarily fund its operations, potentially requiring greater reliance on secondary sources of liquidity to meet withdrawal demands or to fund continuing operations. These sources may include proceeds from Federal Home Loan Bank advances, sales of investment securities and loans, federal funds lines of credit from correspondent banks and out-of-market time deposits. Such reliance on secondary funding sources could increase the Company's overall cost of funding and thereby reduce net income. While the Company believes its current sources of liquidity are adequate to fund operations, there is no guarantee they will suffice to meet future liquidity demands. This may necessitate slowing or discontinuing loan growth, capital expenditures or other investments, or liquidating assets.
New Accounting Guidance adopted in 2023	New Accounting Guidance adopted in 2023 Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” amends the accounting guidance on the impairment of financial instruments. The Financial Accounting Standards Board (“FASB”) issued an amendment to replace the incurred loss impairment methodology under prior accounting guidance with a new current expected credit loss (“CECL”) model. Under the new guidance, the Company is required to measure expected credit losses by utilizing forward-looking information to assess its allowance for credit losses. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. The measurement of expected credit losses under CECL methodology is applicable to financial assets measured at amortized cost, including loans and held to maturity debt securities. CECL also applies to certain off-balance sheet exposures. ​ The Company adopted ASU 2016-13 on January 1, 2023, using the modified retrospective approach for all financial assets measured at amortized cost and off-balance sheet credit exposures. The Company established a governance structure to implement the CECL accounting guidance and has developed a methodology and set of models to be used upon adoption. At adoption, the Company recorded an $0.8 million increase to its allowance for credit losses, entirely related to loans. Further the Company increased its reserve for unfunded credit commitments by $0.1 million. The reserve for unfunded credit commitments is recorded in Accrued expenses and other liabilities on the consolidated balance sheet. These increases in reserves were recorded through retained earnings and was $0.6 million, net of tax. ​ For available for sale securities in an unrealized loss position, the Company first assesses whether it intends to sell, or is more likely than not that it will be required to sell the security before the recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to fair value through income. For securities available for sale that do not meet the above criteria, the Company evaluates whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost and adverse conditions related to the security, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized cost. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income, net of tax. The Company elected the practical expedient of zero loss estimates for securities issued by U.S. government entities and agencies. These securities are either explicitly or implicitly guaranteed by the U.S. government, are highly rated by major agencies and have a long history of no credit losses. ​ For other assets within the scope of the new CECL accounting guidance, such as held to maturity debt securities and other receivables, management noted the impact from adoption to be inconsequential. Additionally, the Company noted the adoption of CECL had no significant impact on regulatory capital ratios of the Company and/or the Bank. ​ ASU 2022-01, “Derivatives and Hedging (Topic 815)”: ASU 2022-01 was issued to clarify the guidance in ASC 815 on fair value hedge accounting of interest rate risk for portfolios and financial assets. Among other things, the amended guidance established the “last-of-layer” method for making the fair value hedge accounting for these portfolios more accessible and renamed that method the “portfolio layer” method. ASU 2022-01 is effective January 1, 2023. The Company adopted the guidance effective January 1, 2023, noting no material impact. ​ ASU 2022-02, “Financial Instruments – Credit Losses (Topic 326)”: ASU 2022-02 eliminates the guidance on troubled debt restructurings (“TDRs”) and requires entities to evaluate all loan modifications to determine if they result in a new loan or a continuation of the existing loan. ASU 2022-02 requires that entities disclose if the modifications result in a new loan or a continuation of the existing loan. ASU 2022-02 also requires that entities disclose current-period gross charge-offs by year of origination for loans and leases. The Company adopted ASU 2022-02 effective January 1, 2023, noting no material impact.

Net Income per Share (Tables)

Net Income per Share (Tables)	9 Months Ended
	Sep. 30, 2023
Net Income per Share
Reconciliation of Calculation of Basic and Diluted Income Per Share	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ ​ For the nine months ended September 30, (In thousands, except per share amounts) 2023 2022 ​ 2023 2022 Net income ​ $ 9,950 ​ $ 9,942 ​ ​ $ 29,937 ​ $ 28,501 Weighted average common shares outstanding - Basic ​ 10,128 ​ 10,522 ​ ​ 10,255 ​ 10,491 Plus: Potential dilutive common stock equivalents ​ 130 ​ 192 ​ ​ 126 ​ 203 Weighted average common shares outstanding - Diluted ​ 10,258 ​ 10,714 ​ ​ 10,381 ​ 10,694 Net income per common share - Basic ​ $ 0.98 ​ $ 0.94 ​ ​ $ 2.92 ​ $ 2.72 Net income per common share - Diluted ​ 0.97 ​ 0.93 ​ ​ 2.88 ​ 2.67 Stock options and common stock excluded from the income per share calculation as their effect would have been anti-dilutive ​ — ​ — ​ ​ — ​ — ​

Other Comprehensive (Loss) In_2

Other Comprehensive (Loss) Income (Tables)	9 Months Ended
	Sep. 30, 2023
Other Comprehensive (Loss) Income
Changes in Other Comprehensive (Loss) Income	The following tables show the changes in other comprehensive (loss) income for the three and nine months ended September 30, 2023 and 2022, net of tax: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, 2023 ​ ​ ​ Accumulated ​ Net unrealized Net unrealized other ​ losses on gains (losses) from comprehensive (In thousands) ​ securities cash flow hedges loss Balance, beginning of period ​ $ (4,631) ​ $ 1,008 ​ $ (3,623) Other comprehensive loss before reclassifications ​ (255) ​ ​ (252) ​ (507) Less amounts reclassified from accumulated other comprehensive loss ​ — ​ ​ (170) ​ (170) Period change ​ (255) ​ (82) ​ (337) Balance, end of period ​ $ (4,886) ​ $ 926 ​ $ (3,960) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, 2022 ​ ​ ​ Net unrealized Accumulated ​ Net unrealized gains other ​ losses on from cash flow comprehensive (In thousands) securities hedges loss Balance, beginning of period ​ $ (3,444) ​ $ 822 ​ $ (2,622) Other comprehensive (loss) income before reclassifications ​ (957) ​ ​ 324 ​ ​ (633) Less amounts reclassified from accumulated other comprehensive loss ​ (455) ​ ​ — ​ ​ (455) Period change ​ (502) ​ ​ 324 ​ ​ (178) Balance, end of period ​ $ (3,946) ​ $ 1,146 ​ $ (2,800) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the nine months ended September 30, 2023 ​ ​ ​ Net unrealized Accumulated ​ ​ Net unrealized gains (losses) other ​ ​ (losses) on from cash flow comprehensive (In thousands) ​ securities hedges loss Balance, beginning of period ​ $ (4,381) ​ $ 1,121 ​ $ (3,260) Other comprehensive loss before reclassifications ​ (505) ​ ​ (664) ​ (1,169) Less amounts reclassified from accumulated other comprehensive loss ​ — ​ ​ (469) ​ (469) Period change ​ (505) ​ (195) ​ (700) Balance, end of period ​ $ (4,886) ​ $ 926 ​ $ (3,960) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the nine months ended September 30, 2022 ​ ​ Net unrealized Accumulated ​ Net unrealized gains other ​ ​ gains (losses) on from cash flow comprehensive (In thousands) ​ securities hedges income (loss) Balance, beginning of period ​ $ 29 ​ $ 293 ​ $ 322 Other comprehensive (loss) income before reclassifications ​ (5,263) ​ ​ 853 ​ (4,410) Less amounts reclassified from accumulated other comprehensive loss ​ (1,288) ​ ​ — ​ (1,288) Period change ​ (3,975) ​ 853 ​ (3,122) Balance, end of period ​ $ (3,946) ​ $ 1,146 ​ $ (2,800)

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value
Balances of Assets And Liabilities Measured at Fair Value on Recurring Basis	The tables below present the balances of assets and liabilities measured at fair value on a recurring basis as of September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measurements at September 30, 2023 ​ ​ ​ ​ ​ Quoted Prices in ​ ​ ​ ​ ​ ​ ​ ​ Assets/Liabilities ​ Active Markets ​ Significant Other ​ Significant ​ ​ Measured at Fair ​ for Identical ​ Observable ​ Unobservable (In thousands) Value Assets (Level 1) Inputs (Level 2) Inputs (Level 3) Measured on a recurring basis: ​ ​ ​ ​ Assets: ​ ​ ​ ​ Debt securities available for sale: ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 16,325 ​ $ — ​ $ 16,325 ​ $ — State and political subdivisions ​ ​ 362 ​ ​ — ​ ​ 362 ​ ​ — Residential mortgage-backed securities ​ 13,670 ​ — ​ 13,670 ​ — Corporate and other securities ​ 61,765 ​ — ​ 57,502 ​ 4,263 Total debt securities available for sale ​ $ 92,122 ​ $ — ​ $ 87,859 ​ $ 4,263 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Equity securities with readily determinable fair values ​ 8,013 ​ 8,013 ​ — ​ — Total equity securities ​ $ 8,013 ​ $ 8,013 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest rate swap agreements ​ 1,264 ​ — ​ 1,264 ​ — Total swap agreements ​ $ 1,264 ​ $ — ​ $ 1,264 ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair value Measurements at December 31, 2022 ​ ​ ​ ​ ​ Quoted Prices in ​ ​ ​ ​ ​ ​ ​ ​ Assets/Liabilities ​ Active Markets ​ Significant Other ​ Significant ​ ​ Measured at Fair ​ for Identical ​ Observable ​ Unobservable (In thousands) Value Assets (Level 1) Inputs (Level 2) Inputs (Level 3) Measured on a recurring basis: ​ ​ ​ ​ Assets: ​ ​ ​ ​ Debt securities available for sale: ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 16,305 ​ $ — ​ $ 16,305 ​ $ — State and political subdivisions ​ 613 ​ ​ — ​ ​ 613 ​ ​ — Residential mortgage-backed securities ​ 15,475 ​ — ​ 15,475 ​ — Corporate and other securities ​ 63,000 ​ — ​ 58,325 ​ 4,675 Total debt securities available for sale ​ $ 95,393 ​ $ — ​ $ 90,718 ​ $ 4,675 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Equity securities with readily determinable fair values ​ 9,793 ​ — ​ 9,793 ​ — Total equity securities ​ $ 9,793 ​ $ — ​ $ 9,793 ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest rate swap agreements ​ 1,537 ​ — ​ 1,537 ​ — Total swap agreements ​ $ 1,537 ​ $ — ​ $ 1,537 ​ $ —
Assets and Liabilities Carried on the Balance Sheet by Caption And By Level Within The Hierarchy	The following tables present the assets and liabilities subject to fair value adjustments on a non-recurring basis carried on the balance sheet by caption and by level within the hierarchy (as described above): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measurements at September 30, 2023 ​ ​ ​ ​ ​ Quoted Prices ​ Significant ​ ​ ​ ​ ​ ​ ​ ​ in Active ​ Other ​ Significant ​ ​ Assets/Liabilities ​ Markets for ​ Observable ​ Unobservable ​ ​ Measured at Fair ​ Identical Assets ​ Inputs ​ Inputs (In thousands) Value (Level 1) (Level 2) (Level 3) Measured on a non-recurring basis: ​ ​ ​ ​ Financial assets: ​ ​ ​ ​ OREO ​ $ 251 ​ $ — ​ $ — ​ $ 251 Collateral-dependent loans ​ $ 13,738 ​ $ — ​ $ — ​ $ 13,738 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measurements at December 31, 2022 ​ ​ ​ ​ ​ Quoted Prices ​ Significant ​ ​ ​ ​ ​ ​ ​ ​ in Active ​ Other ​ Significant ​ ​ Assets/Liabilities ​ Markets for ​ Observable ​ Unobservable ​ ​ Measured at Fair ​ Identical Assets ​ Inputs ​ Inputs (In thousands) Value (Level 1) (Level 2) (Level 3) Measured on a non-recurring basis: ​ ​ ​ ​ Financial assets: ​ ​ ​ ​ Collateral-dependent loans ​ $ 8,803 ​ $ — ​ $ — ​ $ 8,803
Carrying Amount and Estimated Fair Values of Financial Instruments	The table below presents the carrying amount and estimated fair values of the Company’s financial instruments presented as of September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2023 ​ Carrying ​ ​ ​ ​ ​ ​ (In thousands) amount Level 1 Level 2 Level 3 Financial assets: ​ ​ ​ ​ Debt securities held to maturity $ 35,956 ​ $ — ​ $ 27,155 ​ $ — SBA loans held for sale 19,387 ​ — ​ 20,322 ​ — Loans, net of allowance for credit losses 2,127,885 ​ — ​ — ​ 2,027,127 Financial liabilities: ​ ​ ​ ​ ​ ​ ​ Deposits 1,884,910 ​ — ​ 1,871,627 ​ — Borrowed funds and subordinated debentures 398,920 ​ — ​ 397,323 ​ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 ​ Carrying ​ ​ ​ ​ ​ ​ (In thousands) amount Level 1 Level 2 Level 3 Financial assets: ​ ​ ​ ​ Debt securities held to maturity $ 35,760 ​ $ — ​ $ 28,578 ​ $ — SBA loans held for sale 27,928 ​ — ​ 30,141 ​ — Loans, net of allowance for credit losses 2,053,435 ​ — ​ 1,981,207 ​ 8,803 Financial liabilities: ​ ​ ​ ​ ​ ​ ​ Deposits 1,787,528 ​ — ​ 1,772,270 ​ — Borrowed funds and subordinated debentures 393,310 ​ — ​ 391,312 ​ — ​ ​

Securities (Tables)

Securities (Tables)	9 Months Ended
	Sep. 30, 2023
Securities
Reconciliation From Amortized Cost to Estimated Fair Value of Marketable Securities	This table provides the major components of debt securities available for sale ("AFS") and held to maturity (“HTM”) at amortized cost and estimated fair value at September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2023 ​ December 31, 2022 ​ ​ ​ Gross Gross ​ ​ ​ ​ Gross Gross ​ ​ ​ ​ Amortized ​ unrealized ​ unrealized ​ Estimated ​ Amortized ​ unrealized ​ unrealized ​ Estimated (In thousands) ​ cost ​ gains ​ losses ​ fair value ​ cost ​ gains ​ losses ​ fair value Available for sale: ​ ​ ​ ​ ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 17,133 ​ $ — ​ $ (808) ​ $ 16,325 ​ $ 16,961 ​ $ — ​ $ (656) ​ $ 16,305 State and political subdivisions ​ 407 ​ — ​ (45) ​ 362 ​ 635 ​ — ​ (22) ​ 613 Residential mortgage-backed securities ​ 15,835 ​ 28 ​ (2,193) ​ 13,670 ​ 17,097 ​ 32 ​ (1,654) ​ 15,475 Corporate and other securities ​ 65,202 ​ 121 ​ (3,558) ​ 61,765 ​ 66,495 ​ 106 ​ (3,601) ​ 63,000 Total debt securities available for sale ​ $ 98,577 ​ $ 149 ​ $ (6,604) ​ $ 92,122 ​ $ 101,188 ​ $ 138 ​ $ (5,933) ​ $ 95,393 Held to maturity: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 28,000 ​ $ — ​ $ (6,096) ​ $ 21,904 ​ $ 28,000 ​ $ — ​ $ (5,310) ​ $ 22,690 State and political subdivisions ​ 1,158 ​ 5 ​ (3) ​ 1,160 ​ 1,115 ​ 67 ​ — ​ 1,182 Residential mortgage-backed securities ​ 6,798 ​ — ​ (2,707) ​ 4,091 ​ 6,645 ​ — ​ (1,939) ​ 4,706 Total debt securities held to maturity ​ $ 35,956 ​ $ 5 ​ $ (8,806) ​ $ 27,155 ​ $ 35,760 ​ $ 67 ​ $ (7,249) ​ $ 28,578
Schedule of Marketable Securities By Contractual Maturity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amortized ​ ​ Fair (In thousands) ​ Cost ​ ​ Value Available for sale: ​ ​ ​ ​ Due in one year $ 2,133 ​ $ 2,114 Due after one year through five years ​ 30,779 ​ ​ 29,404 Due after five years through ten years ​ 10,984 ​ ​ 9,616 Due after ten years ​ 38,846 ​ ​ 37,318 Residential mortgage-backed securities ​ 15,835 ​ ​ 13,670 Total $ 98,577 ​ $ 92,122 Held to maturity: ​ ​ ​ ​ ​ Due in one year $ — ​ $ — Due after one year through five years ​ — ​ ​ — Due after five years through ten years ​ 3,000 ​ ​ 2,819 Due after ten years ​ 26,158 ​ ​ 20,245 Residential mortgage-backed securities ​ 6,798 ​ ​ 4,091 Total $ 35,956 ​ $ 27,155
Schedule of Marketable Securities In Unrealized Loss Position	The fair value of debt securities with unrealized losses by length of time that the individual securities have been in a continuous unrealized loss position at September 30, 2023 and December 31, 2022 are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2023 ​ ​ ​ Less than 12 months ​ 12 months and greater ​ Total ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Estimated ​ Unrealized ​ Estimated ​ Unrealized ​ Estimated ​ Unrealized (In thousands) ​ ​ fair value ​ loss ​ fair value ​ loss ​ fair value ​ loss Available for sale: ​ ​ ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 2,114 ​ $ (19) ​ $ 14,211 ​ $ (789) ​ $ 16,325 ​ $ (808) State and political subdivisions ​ ​ — ​ ​ — ​ ​ 362 ​ ​ (45) ​ ​ 362 ​ ​ (45) Residential mortgage-backed securities ​ ​ 81 ​ ​ (3) ​ ​ 13,543 ​ ​ (2,190) ​ ​ 13,624 ​ ​ (2,193) Corporate and other securities ​ ​ 4,692 ​ ​ (308) ​ ​ 54,452 ​ ​ (3,250) ​ ​ 59,144 ​ ​ (3,558) Total ​ ​ $ 6,887 ​ $ (330) ​ $ 82,568 ​ $ (6,274) ​ $ 89,455 ​ $ (6,604) Held to maturity: ​ ​ ​ ​ ​ ​ U.S. Government sponsored entities ​ $ — ​ $ — ​ $ 21,904 ​ $ (6,096) ​ $ 21,904 ​ $ (6,096) State and political subdivisions ​ ​ ​ 571 ​ ​ (3) ​ ​ — ​ ​ — ​ ​ 571 ​ ​ (3) Residential mortgage-backed securities ​ ​ ​ — ​ $ — ​ ​ 4,091 ​ ​ (2,707) ​ ​ 4,091 ​ ​ (2,707) Total ​ $ 571 ​ $ (3) ​ $ 25,995 ​ $ (8,803) ​ $ 26,566 ​ $ (8,806) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 ​ ​ ​ Less than 12 months ​ 12 months and greater ​ Total ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Estimated ​ Unrealized ​ Estimated ​ Unrealized ​ Estimated ​ Unrealized (In thousands) ​ ​ fair value ​ loss ​ fair value ​ loss ​ fair value ​ loss Available for sale: ​ ​ ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 15,817 ​ $ (622) ​ $ 1,432 ​ $ (34) ​ $ 17,249 ​ $ (656) State and political subdivisions ​ ​ 160 ​ ​ (5) ​ ​ 253 ​ ​ (17) ​ ​ 413 ​ ​ (22) Residential mortgage-backed securities ​ 14,023 ​ ​ (1,448) ​ ​ 1,311 ​ ​ (206) ​ ​ 15,334 ​ ​ (1,654) Corporate and other securities ​ ​ 23,445 ​ (966) ​ 31,948 ​ (2,635) ​ 55,393 ​ (3,601) Total temporarily impaired AFS securities ​ $ 53,445 ​ $ (3,041) ​ $ 34,944 ​ $ (2,892) ​ $ 88,389 ​ $ (5,933) Held to maturity: ​ ​ ​ ​ ​ ​ ​ U.S. Government sponsored entities ​ $ 15,659 ​ $ (2,341) ​ $ 7,031 ​ $ (2,969) ​ $ 22,690 ​ $ (5,310) Residential mortgage-backed securities ​ 4,707 ​ (1,939) ​ — ​ — ​ 4,707 ​ (1,939) Total temporarily impaired HTM securities ​ $ 20,366 ​ $ (4,280) ​ $ 7,031 ​ $ (2,969) ​ $ 27,397 ​ $ (7,249)
Equity Securities, Gains and Losses	The following is a summary of unrealized and realized gains and losses recognized in net income on equity securities during the three and nine months ended September 30, 2023 and 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ For the nine months ended September 30, (In thousands) 2023 2022 2023 2022 Net unrealized losses occurring during the period on equity securities ​ $ (144) ​ $ (576) ​ $ (853) ​ $ (1,631) Net realized gains recognized during the period on equity securities sold during the period ​ 21 ​ — ​ 243 ​ — Net losses recognized during the reporting period on equity securities still held at the reporting date ​ $ (123) ​ $ (576) ​ $ (610) ​ $ (1,631)

Loans (Tables)

Loans (Tables)	9 Months Ended
	Sep. 30, 2023
Loans
Classification of Loans By Class	The following table sets forth the classification of loans by class, including unearned fees, deferred costs and excluding the allowance for loan losses as of September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ (In thousands) September 30, 2023 December 31, 2022 SBA loans held for investment ​ $ 40,873 ​ $ 38,468 SBA PPP loans ​ ​ 2,507 ​ ​ 5,908 Commercial loans ​ ​ ​ SBA 504 loans ​ 31,808 ​ 35,077 Commercial other ​ 130,967 ​ 117,566 Commercial real estate ​ 968,801 ​ 903,126 Commercial real estate construction ​ 144,580 ​ 131,774 Residential mortgage loans ​ 628,628 ​ 605,091 Consumer loans ​ ​ ​ ​ Home equity ​ 65,461 ​ 68,310 Consumer other ​ ​ 6,728 ​ ​ 9,854 Residential construction loans ​ ​ 133,450 ​ ​ 163,457 Total loans held for investment ​ $ 2,153,803 ​ $ 2,078,631 SBA loans held for sale ​ 19,387 ​ 27,928 Total loans ​ $ 2,173,190 ​ $ 2,106,559
Aging Analysis of Past Due And Nonaccrual Loans by Loan Class	The following tables set forth an aging analysis of past due and nonaccrual loans as of September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2023 ​ ​ ​ ​ ​ 90+ days ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 30 ‑ 59 days ​ 60 ‑ 89 days ​ and still ​ ​ ​ Total past ​ ​ ​ ​ ​ ​ (In thousands) ​ past due ​ past due ​ accruing ​ Nonaccrual ​ due ​ Current ​ Total loans SBA loans held for investment ​ $ 4,083 ​ $ 420 ​ $ — ​ $ 3,445 ​ $ 7,948 ​ $ 32,925 ​ $ 40,873 Commercial loans ​ ​ ​ ​ ​ ​ ​ ​ SBA 504 loans ​ — ​ — ​ — ​ — ​ — ​ 31,808 ​ 31,808 Commercial other ​ — ​ — ​ — ​ 668 ​ 668 ​ 130,299 ​ 130,967 Commercial real estate ​ 553 ​ — ​ — ​ 82 ​ 635 ​ 968,166 ​ 968,801 Commercial real estate construction ​ — ​ — ​ — ​ — ​ — ​ 144,580 ​ 144,580 Residential mortgage loans ​ 4,961 ​ 3,347 ​ 260 ​ 10,270 ​ 18,838 ​ 609,790 ​ 628,628 Consumer loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Home equity ​ 286 ​ 15 ​ — ​ 125 ​ 426 ​ 65,035 ​ 65,461 Consumer other ​ ​ 1,319 ​ ​ 52 ​ ​ 5 ​ ​ — ​ ​ 1,376 ​ ​ 5,352 ​ ​ 6,728 Residential construction loans ​ ​ — ​ ​ — ​ ​ — ​ ​ 3,201 ​ ​ 3,201 ​ ​ 130,249 ​ ​ 133,450 Total loans held for investment, excluding SBA PPP ​ ​ 11,202 ​ ​ 3,834 ​ ​ 265 ​ ​ 17,791 ​ ​ 33,092 ​ ​ 2,118,204 ​ ​ 2,151,296 SBA loans held for sale ​ 815 ​ — ​ — ​ — ​ 815 ​ 18,572 ​ 19,387 Total loans, excluding SBA PPP ​ $ 12,017 ​ $ 3,834 ​ $ 265 ​ $ 17,791 ​ $ 33,907 ​ $ 2,136,776 ​ $ 2,170,683 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 ​ ​ ​ ​ ​ 90+ days ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 30 ‑ 59 days ​ 60 ‑ 89 days ​ and still ​ ​ ​ Total past ​ ​ ​ ​ ​ ​ (In thousands) ​ past due ​ past due ​ accruing ​ Nonaccrual ​ due ​ Current ​ Total loans SBA loans held for investment ​ $ — ​ $ 576 ​ $ — ​ $ 690 ​ $ 1,266 ​ $ 37,202 ​ $ 38,468 Commercial loans ​ ​ ​ ​ ​ ​ ​ SBA 504 loans ​ — ​ — ​ — ​ — ​ — ​ 35,077 ​ 35,077 Commercial other ​ 198 ​ 300 ​ — ​ 777 ​ 1,275 ​ 116,291 ​ 117,566 Commercial real estate ​ 22 ​ 188 ​ — ​ 805 ​ 1,015 ​ 902,111 ​ 903,126 Commercial real estate construction ​ — ​ — ​ — ​ — ​ — ​ 131,774 ​ 131,774 Residential mortgage loans ​ — ​ 982 ​ — ​ 3,361 ​ 4,343 ​ 600,748 ​ 605,091 Consumer loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Home equity ​ — ​ — ​ — ​ — ​ — ​ 68,310 ​ 68,310 Consumer other ​ ​ 18 ​ 7 ​ — ​ — ​ 25 ​ 9,829 ​ 9,854 Residential construction loans ​ ​ — ​ ​ — ​ ​ — ​ ​ 3,432 ​ ​ 3,432 ​ ​ 160,025 ​ ​ 163,457 Total loans held for investment, excluding SBA PPP ​ ​ 238 ​ ​ 2,053 ​ ​ — ​ ​ 9,065 ​ ​ 11,356 ​ ​ 2,061,367 ​ ​ 2,072,723 SBA loans held for sale ​ 2,195 ​ — ​ — ​ — ​ 2,195 ​ 25,733 ​ 27,928 Total loans, excluding SBA PPP ​ $ 2,433 ​ $ 2,053 ​ $ — ​ $ 9,065 ​ $ 13,551 ​ $ 2,087,100 ​ $ 2,100,651
Schedule of Loan Classification Risk by Loan Portfolio Classification by Origination Year	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Term Loans ​ ​ ​ ​ ​ ​ ​ Amortized Cost Basis by Origination Year ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ (In thousands) ​ ​ 2023 ​ ​ 2022 ​ ​ 2021 ​ ​ 2020 ​ ​ 2019 ​ ​ 2018 and Earlier ​ ​ Revolving Loans Amortized Cost Basis ​ ​ Total SBA loans held for investment ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Risk Rating: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Pass ​ $ 1,057 ​ $ 7,113 ​ $ 5,151 ​ $ 6,131 ​ $ 2,669 ​ $ 11,334 ​ $ - ​ $ 33,455 Special Mention ​ ​ - ​ ​ 1,797 ​ ​ - ​ ​ 510 ​ ​ - ​ ​ 778 ​ ​ - ​ ​ 3,085 Substandard ​ ​ - ​ ​ 1,256 ​ ​ 2,225 ​ ​ 190 ​ ​ - ​ ​ 662 ​ ​ - ​ ​ 4,333 Total SBA loans held for investment ​ $ 1,057 ​ $ 10,166 ​ $ 7,376 ​ $ 6,831 ​ $ 2,669 ​ $ 12,774 ​ $ - ​ $ 40,873 SBA loans held for investment ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Current-period gross writeoffs ​ $ - ​ $ 100 ​ $ - ​ $ - ​ $ 113 ​ $ - ​ $ - ​ $ 213 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ SBA PPP loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Risk Rating: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Pass ​ $ - ​ $ - ​ $ 2,507 ​ $ - ​ $ - ​ $ - ​ $ - ​ $ 2,507 Special Mention ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - Substandard ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - Total SBA PPP loans ​ $ - ​ $ - ​ $ 2,507 ​ $ - ​ $ - ​ $ - ​ $ - ​ $ 2,507 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Commercial loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Risk Rating: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Pass ​ $ 101,748 ​ $ 358,414 ​ $ 186,930 ​ $ 136,850 ​ $ 102,312 ​ $ 278,861 ​ $ 95,372 ​ $ 1,260,487 Special Mention ​ ​ - ​ ​ 82 ​ ​ 212 ​ ​ - ​ ​ 1,727 ​ ​ 10,307 ​ ​ 645 ​ ​ 12,973 Substandard ​ ​ - ​ ​ - ​ ​ - ​ ​ 236 ​ ​ - ​ ​ 2,460 ​ ​ - ​ ​ 2,696 Total commercial loans ​ $ 101,748 ​ $ 358,496 ​ $ 187,142 ​ $ 137,086 ​ $ 104,039 ​ $ 291,628 ​ $ 96,017 ​ $ 1,276,156 Commercial loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Current-period gross writeoffs ​ $ - ​ $ - ​ $ 150 ​ $ - ​ $ 350 ​ $ - ​ $ - ​ $ 500 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential mortgage loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Risk Rating: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Performing ​ $ 83,675 ​ $ 259,430 ​ $ 73,961 ​ $ 52,432 ​ $ 32,944 ​ $ 115,498 ​ $ - ​ $ 617,940 Nonperforming ​ ​ 5,032 ​ ​ 2,174 ​ ​ 550 ​ ​ 1,055 ​ ​ 276 ​ ​ 1,601 ​ ​ - ​ ​ 10,688 Total residential mortgage loans ​ $ 88,707 ​ $ 261,604 ​ $ 74,511 ​ $ 53,487 ​ $ 33,220 ​ $ 117,099 ​ $ - ​ $ 628,628 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Consumer loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Risk Rating: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Performing ​ $ 3,041 ​ $ 5,103 ​ $ 4,450 ​ $ 696 ​ $ 2,589 ​ $ 8,045 ​ $ 47,875 ​ $ 71,799 Nonperforming ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ - ​ ​ 390 ​ ​ 390 Total consumer loans ​ $ 3,041 ​ $ 5,103 ​ $ 4,450 ​ $ 696 ​ $ 2,589 ​ $ 8,045 ​ $ 48,265 ​ $ 72,189 Consumer loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Current-period gross writeoffs ​ $ - ​ $ - ​ $ 397 ​ $ - ​ $ - ​ $ - ​ $ - ​ $ 397 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential construction ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Risk Rating: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Performing ​ $ 20,697 ​ $ 72,544 ​ $ 34,165 ​ $ 1,550 ​ $ 500 ​ $ 732 ​ $ - ​ $ 130,188 Nonperforming ​ ​ - ​ ​ - ​ ​ 377 ​ ​ 547 ​ ​ - ​ ​ 1,303 ​ ​ 1,035 ​ ​ 3,262 Total residential construction loans ​ $ 20,697 ​ $ 72,544 ​ $ 34,542 ​ $ 2,097 ​ $ 500 ​ $ 2,035 ​ $ 1,035 ​ $ 133,450 Residential construction ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Current-period gross writeoffs ​ $ - ​ $ - ​ $ - ​ $ - ​ $ - ​ $ 500 ​ $ 400 ​ $ 900 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total loans held for investment ​ $ 215,250 ​ $ 707,913 ​ $ 310,528 ​ $ 200,197 ​ $ 143,017 ​ $ 431,581 ​ $ 145,317 ​ $ 2,153,803
Loan Portfolio by Class According to Their Credit Quality Indicators	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 ​ ​ SBA & Commercial loans - Internal risk ratings (In thousands) Pass Special mention Substandard Total SBA loans held for investment ​ $ 37,163 ​ $ 558 ​ $ 747 ​ $ 38,468 SBA PPP loans ​ ​ 5,908 ​ ​ — ​ ​ — ​ ​ 5,908 Commercial loans ​ ​ ​ ​ SBA 504 loans ​ 35,077 ​ — ​ — ​ 35,077 Commercial other ​ 110,107 ​ 6,220 ​ 1,239 ​ 117,566 Commercial real estate ​ 894,110 ​ 6,228 ​ 2,788 ​ 903,126 Commercial real estate construction ​ 131,774 ​ — ​ — ​ 131,774 Total commercial loans ​ 1,171,068 ​ 12,448 ​ 4,027 ​ 1,187,543 Total SBA and commercial loans ​ $ 1,214,139 ​ $ 13,006 ​ $ 4,774 ​ $ 1,231,919 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential mortgage, Consumer & Residential construction loans - Performing/Nonperforming (In thousands) ​ ​ Performing ​ Nonperforming ​ Total Residential mortgage loans ​ ​ $ 601,730 ​ $ 3,361 ​ $ 605,091 Consumer loans ​ ​ ​ ​ ​ Home equity ​ ​ 68,310 ​ — ​ 68,310 Consumer other ​ ​ ​ ​ ​ 9,854 ​ — ​ 9,854 Total consumer loans ​ ​ ​ ​ ​ 78,164 ​ — ​ 78,164 Residential construction loans ​ ​ ​ ​ ​ 160,025 ​ ​ 3,432 ​ ​ 163,457 Total residential mortgage, consumer and residential construction loans ​ ​ $ 839,919 ​ $ 6,793 ​ $ 846,712
Schedule of Amortized Cost Basis of Loans Modified, Disaggregated by Class of Gross Loans and Type of Concession Granted	The following table shows the amortized cost basis at the end of the reporting period of the loans modified to borrowers experiencing financial difficulty, disaggregated by class of gross loans and type of concession granted (numbers in thousands) during the nine months ended September 30, 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Term Extension ​ ​ ​ Amortized Cost Basis ​ % of Total Class of ​ ​ ​ ​ September 30, 2023 ​ Gross Loans ​ Commercial ​ $ 952 ​ 0.1 % ​ ​ ​ ​ ​ ​ ​ ​ ​ Principal Forgiveness/Deferment ​ ​ ​ Amortized Cost Basis ​ % of Total Class of ​ ​ ​ ​ September 30, 2023 ​ Gross Loans ​ SBA ​ $ 9 ​ 0.0 %

Allowance for Credit Losses a_2

Allowance for Credit Losses and Reserve for Unfunded Loan Commitments (Tables)	9 Months Ended
	Sep. 30, 2023
Allowance for Credit Losses and Reserve for Unfunded Loan Commitments
Activity in the Allowance for Loan Losses by Portfolio Segment	The following tables detail the activity in the allowance for credit losses by portfolio segment for the three and nine months ended September 30, 2023 and 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, 2023 ​ ​ ​ SBA ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential ​ ​ ​ (In thousands) ​ Held for Investment ​ Commercial ​ Residential ​ Consumer ​ construction ​ Total Balance, beginning of period ​ $ 1,556 ​ $ 15,516 ​ $ 6,437 ​ $ 845 ​ $ 1,634 ​ $ 25,988 Charge-offs ​ (100) ​ (500) ​ — ​ (52) ​ — ​ (652) Recoveries ​ 1 ​ 10 ​ — ​ 37 ​ — ​ 48 Net (charge-offs) recoveries ​ (99) ​ (490) ​ — ​ (15) ​ — ​ (604) Provision for (credit to) credit losses charged to expense ​ 199 ​ 325 ​ (6) ​ 130 ​ (114) ​ 534 Balance, end of period ​ $ 1,656 ​ $ 15,351 ​ $ 6,431 ​ $ 960 ​ $ 1,520 ​ $ 25,918 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential ​ ​ ​ (In thousands) ​ SBA ​ Commercial ​ Residential ​ Consumer ​ construction ​ Total Balance, beginning of period ​ $ 758 ​ $ 14,908 ​ $ 4,786 ​ $ 803 ​ $ 1,603 ​ $ 22,858 Charge-offs ​ — ​ (501) ​ — ​ (50) ​ — ​ (551) Recoveries ​ 5 ​ 23 ​ — ​ 9 ​ — ​ 37 Net recoveries (charge-offs) ​ 5 ​ (478) ​ — ​ (41) ​ — ​ (514) Provision for (credit to) credit losses charged to expense ​ 68 ​ 803 ​ 449 ​ 349 ​ (152) ​ 1,517 Balance, end of period ​ $ 831 ​ $ 15,233 ​ $ 5,235 ​ $ 1,111 ​ $ 1,451 ​ $ 23,861 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the nine months ended September 30, 2023 ​ ​ ​ SBA ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential ​ ​ ​ (In thousands) ​ Held for Investment ​ Commercial ​ Residential ​ Consumer ​ construction ​ Total Balance, beginning of period ​ $ 875 ​ $ 15,254 ​ $ 5,450 ​ $ 990 ​ $ 2,627 ​ $ 25,196 Effect of adopting Accounting Standards Update ("ASU") No. 2016-13 ("CECL") ​ ​ 163 ​ ​ 171 ​ ​ 376 ​ ​ 101 ​ ​ 36 ​ ​ 847 Charge-offs ​ (213) ​ (500) ​ — ​ (397) ​ (900) ​ (2,010) Recoveries ​ 16 ​ 377 ​ — ​ 73 ​ — ​ 466 Net (charge-offs) recoveries ​ (197) ​ (123) ​ — ​ (324) ​ (900) ​ (1,544) Provision for (credit to) loan losses charged to expense ​ 815 ​ 49 ​ 605 ​ 193 ​ (243) ​ 1,419 Balance, end of period ​ $ 1,656 ​ $ 15,351 ​ $ 6,431 ​ $ 960 ​ $ 1,520 ​ $ 25,918 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the nine months ended September 30, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential ​ ​ ​ (In thousands) ​ SBA ​ Commercial ​ Residential ​ Consumer ​ construction ​ Total Balance, beginning of period ​ $ 1,074 ​ $ 15,053 ​ $ 4,114 ​ $ 671 ​ $ 1,390 ​ $ 22,302 Charge-offs ​ — ​ (1,001) ​ — ​ (96) ​ — ​ (1,097) Recoveries ​ 33 ​ 83 ​ 1 ​ 13 ​ — ​ 130 Net (charge-offs) recoveries ​ 33 ​ (918) ​ 1 ​ (83) ​ — ​ (967) Provision (credit) for loan losses charged to expense ​ (276) ​ 1,098 ​ 1,120 ​ 523 ​ 61 ​ 2,526 Balance, end of period ​ $ 831 ​ $ 15,233 ​ $ 5,235 ​ $ 1,111 ​ $ 1,451 ​ $ 23,861 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
Allowance for Credit Losses on Financing Receivables	The following tables present loans and their related allowance for credit losses, by portfolio segment, as of September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2023 ​ ​ ​ SBA ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential ​ ​ ​ (In thousands) ​ Held for Investment ​ Commercial ​ Residential ​ Consumer ​ construction ​ Total Allowance for credit losses ending balance: ​ ​ ​ ​ ​ ​ Individually evaluated ​ $ 619 ​ $ 369 ​ $ 386 ​ $ — ​ $ 285 ​ $ 1,659 Collectively evaluated ​ 1,037 ​ 14,982 ​ 6,045 ​ 960 ​ 1,235 ​ 24,259 Total ​ $ 1,656 ​ $ 15,351 ​ $ 6,431 ​ $ 960 ​ $ 1,520 ​ $ 25,918 Loan ending balances: ​ ​ ​ ​ ​ ​ Individually evaluated ​ $ 256 ​ $ 750 ​ $ 11,059 ​ $ 131 ​ $ 3,201 ​ $ 15,397 Collectively evaluated ​ 40,617 ​ 1,275,406 ​ 617,569 ​ 72,058 ​ 130,249 ​ 2,135,899 Total ​ $ 40,873 ​ $ 1,276,156 ​ $ 628,628 ​ $ 72,189 ​ $ 133,450 ​ $ 2,151,296 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Residential ​ ​ ​ (In thousands) ​ SBA ​ Commercial ​ Residential ​ Consumer ​ construction ​ Total Allowance for credit losses ending balance: ​ ​ ​ ​ ​ ​ ​ Individually evaluated for impairment ​ $ 115 ​ $ 516 ​ $ 36 ​ $ — ​ $ 1,112 ​ $ 1,779 Collectively evaluated for impairment ​ 760 ​ 14,738 ​ 5,414 ​ 990 ​ 1,515 ​ 23,417 Total ​ $ 875 ​ $ 15,254 ​ $ 5,450 ​ $ 990 ​ $ 2,627 ​ $ 25,196 Loan ending balances: ​ ​ ​ ​ ​ ​ ​ Individually evaluated for impairment ​ $ 690 ​ $ 3,101 ​ $ 3,361 ​ $ — ​ $ 3,432 ​ $ 10,584 Collectively evaluated for impairment ​ 71,614 ​ 1,184,442 ​ 601,730 ​ 78,164 ​ 160,025 ​ 2,095,975 Total ​ $ 72,304 ​ $ 1,187,543 ​ $ 605,091 ​ $ 78,164 ​ $ 163,457 ​ $ 2,106,559

Derivative Financial Instrume_2

Derivative Financial Instruments and Hedging Activities (Tables)	9 Months Ended
	Sep. 30, 2023
Derivative Financial Instruments and Hedging Activities
Summary of Interest Rate Swaps	​ ​ ​ ​ ​ ​ ​ ​ ​ (In thousands, except percentages and years) September 30, 2023 December 31, 2022 Notional amount ​ $ 20,000 ​ $ 20,000 ​ Fair value ​ $ 1,264 ​ $ 1,537 ​ Weighted average pay rate ​ 0.83 % 0.83 % Weighted average receive rate ​ 5.56 % 1.50 % Weighted average maturity in years ​ 1.44 ​ 2.57 ​ Number of contracts ​ 1 ​ 1 ​
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ For the nine months ended September 30, ​ (In thousands) 2023 2022 ​ 2023 2022 ​ (Loss) Gain recognized in OCI ​ $ (139) $ 452 ​ $ (273) ​ $ 1,386 ​ Gain reclassified from AOCI into net income $ 238 $ — ​ $ 656 $ — ​ ​

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	9 Months Ended
	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award
Transactions under the Company's stock option plans	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ Weighted ​ average ​ ​ ​ ​ ​ ​ ​ average ​ remaining ​ Aggregate ​ ​ ​ ​ exercise ​ contractual ​ intrinsic ​ ​ Shares ​ price ​ life in years ​ value Outstanding at December 31, 2022 559,499 ​ $ 18.09 5.9 ​ $ 5,168,740 Options granted — ​ ​ ​ Options exercised (73,184) 19.04 ​ Options forfeited (1,332) ​ 18.64 ​ Options expired — ​ ​ ​ Outstanding at September 30, 2023 484,983 ​ $ 17.95 5.2 ​ $ 2,659,163 Exercisable at September 30, 2023 ​ 445,825 ​ $ 17.85 5.0 ​ $ 2,488,426
Schedule of Information About Options Exercised	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ For the nine months ended September 30, ​ ​ 2023 2022 2023 2022 ​ Number of options exercised ​ 22,249 ​ ​ 23,168 ​ 73,184 85,877 ​ Total intrinsic value of options exercised ​ $ 164,978 ​ ​ 215,476 ​ $ 480,981 $ 1,081,833 ​ Cash received from options exercised ​ $ 394,665 ​ ​ 441,272 ​ 1,393,551 1,394,809 ​ Tax deduction realized from options ​ $ 49,634 ​ ​ 64,826 ​ 144,703 325,469 ​
Schedule of Stock Options, by Exercise Price Range	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Options outstanding ​ Options exercisable ​ ​ ​ Weighted average Weighted ​ Weighted ​ ​ Options ​ remaining contractual ​ average ​ Options ​ average Range of exercise prices ​ outstanding ​ life (in years) ​ exercise price ​ exercisable ​ exercise price $7.25 - 16.51 128,873 3.4 ​ $ 12.01 128,873 ​ $ 12.01 16.52 - 19.26 120,499 6.0 ​ 18.03 97,674 ​ 18.04 19.27 - 20.88 ​ 127,411 ​ 5.9 ​ ​ 20.33 ​ 111,078 ​ ​ 20.30 20.89 - 22.57 108,200 5.8 ​ 22.11 108,200 ​ 22.11 Total 484,983 5.2 ​ $ 17.95 445,825 ​ $ 17.85
Schedule of Nonvested Share Activity	​ ​ ​ ​ ​ ​ ​ ​ ​ Average grant ​ ​ Shares ​ date fair value Nonvested restricted stock at December 31, 2022 164,570 ​ $ 24.77 Granted 58,500 ​ ​ 22.93 Cancelled (4,599) ​ ​ 26.37 Vested (41,973) ​ ​ 23.13 Nonvested restricted stock at September 30, 2023 176,498 ​ $ 24.51
Restricted Stock Grants	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ For the nine months ended September 30, ​ 2023 2022 ​ 2023 2022 Number of shares granted ​ 3,000 ​ 2,000 ​ ​ 58,500 ​ 73,000 Average grant date fair value ​ $ 25.24 ​ $ 27.89 ​ $ 22.93 ​ $ 27.54
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Allocation of Share-based Compensation Costs	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ For the nine months ended September 30, ​ (In thousands) 2023 2022 ​ 2023 2022 ​ Compensation expense ​ $ 72 ​ $ 129 ​ $ 236 ​ $ 431 ​ Income tax benefit ​ $ 21 ​ $ 37 ​ $ 68 ​ $ 125 ​
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Allocation of Share-based Compensation Costs	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended September 30, ​ For the nine months ended September 30, ​ (In thousands) 2023 2022 ​ 2023 2022 ​ Compensation expense ​ $ 357 ​ $ 276 ​ $ 1,033 ​ $ 808 ​ Income tax benefit ​ $ 103 ​ $ 80 ​ $ 298 ​ $ 234 ​

Regulatory Capital (Tables)

Regulatory Capital (Tables)	9 Months Ended
	Sep. 30, 2023
Regulatory Capital
Schedule of Compliance with Regulatory Capital Requirements under Banking Regulations	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ At September 30, 2023 ​ ​ At December 31, 2022 ​ ​ Company Bank Company Bank CBLR 10.76 % 10.35 % 10.88 % 10.34 % ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Significant Accounting Polici_3

Significant Accounting Policies (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment
Increase to allowance for credit losses	$ 25,918
Reserve for unfunded credit commitments	25,380	$ 24,192
Retained earnings	182,557	156,958
Cumulative effect, period of adjustment
Property, Plant and Equipment
Increase to allowance for credit losses	$ 847
Accounting Standards Update No. 2016-13 | Cumulative effect, period of adjustment
Property, Plant and Equipment
Increase to allowance for credit losses		800
Reserve for unfunded credit commitments		100
Retained earnings		$ 600

Net Income per Share (Details)

Net Income per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Net Income per Share
Net income	$ 9,950	$ 9,700	$ 10,287	$ 9,942	$ 9,451	$ 9,108	$ 29,937	$ 28,501
Weighted average common shares outstanding - Basic (in shares)	10,128			10,522			10,255	10,491
Plus: Potential dilutive common stock equivalents (in shares)	130			192			126	203
Weighted average common shares outstanding - Diluted (in shares)	10,258			10,714			10,381	10,694
Net income per common share - Basic	$ 0.98			$ 0.94			$ 2.92	$ 2.72
Net income per common share - Diluted	$ 0.97			$ 0.93			$ 2.88	$ 2.67

Other Comprehensive (Loss) In_3

Other Comprehensive (Loss) Income (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	$ 244,073	$ 240,459	$ 239,227	$ 220,789	$ 214,928	$ 205,729	$ 239,227	$ 205,729
Period change	(337)	(444)	81	(178)	(3,230)	286	(700)	(3,122)
Ending balance	252,384	244,073	240,459	230,234	220,789	214,928	252,384	230,234
Net unrealized losses on securities
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	(4,631)		(4,381)	(3,444)		29	(4,381)	29
Other comprehensive loss before reclassifications	(255)			(957)			(505)	(5,263)
Less amounts reclassified from accumulated other comprehensive loss				(455)				(1,288)
Period change	(255)			(502)			(505)	(3,975)
Ending balance	(4,886)	(4,631)		(3,946)	(3,444)		(4,886)	(3,946)
Net unrealized gains (losses) from cash flow hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	1,008		1,121	822		293	1,121	293
Other comprehensive loss before reclassifications	(252)			324			(664)	853
Less amounts reclassified from accumulated other comprehensive loss	(170)						(469)
Period change	(82)			324			(195)	853
Ending balance	926	1,008		1,146	822		926	1,146
Accumulated other comprehensive loss
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	(3,623)	(3,179)	(3,260)	(2,622)	608	322	(3,260)	322
Other comprehensive loss before reclassifications	(507)			(633)			(1,169)	(4,410)
Less amounts reclassified from accumulated other comprehensive loss	(170)			(455)			(469)	(1,288)
Period change	(337)	(444)	81	(178)	(3,230)	286	(700)	(3,122)
Ending balance	$ (3,960)	$ (3,623)	$ (3,179)	$ (2,800)	$ (2,622)	$ 608	$ (3,960)	$ (2,800)

Fair Value - Fair Value on Recu

Fair Value - Fair Value on Recurring Basis - Narrative (Details) $ in Thousands	Sep. 30, 2023 USD ($) security	Dec. 31, 2022 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Estimated fair value	$ 92,122
Equity securities	$ 8,013	$ 9,793
Corporate Bond Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities classified as Level 3 assets | security	2

Fair Value - Assets And Liabili

Fair Value - Assets And Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		$ 95,393
Debt securities available-for-sale	$ 92,122
Equity securities	8,013	9,793
U.S. Government sponsored entities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		16,305
Debt securities available-for-sale	16,325
State and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		613
Debt securities available-for-sale	362
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		15,475
Debt securities available-for-sale	13,670
Corporate and other securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		63,000
Debt securities available-for-sale	61,765
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		95,393
Debt securities available-for-sale	92,122
Equity securities	8,013	9,793
Swap agreements	1,264	1,537
Liabilities measured at fair value	0	0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Equity securities	8,013
Recurring | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		90,718
Debt securities available-for-sale	87,859
Equity securities		9,793
Swap agreements	1,264	1,537
Recurring | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		4,675
Debt securities available-for-sale	4,263
Recurring | U.S. Government sponsored entities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		16,305
Debt securities available-for-sale	16,325
Recurring | U.S. Government sponsored entities | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		16,305
Debt securities available-for-sale	16,325
Recurring | State and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		613
Debt securities available-for-sale	362
Recurring | State and political subdivisions | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		613
Debt securities available-for-sale	362
Recurring | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		15,475
Debt securities available-for-sale	13,670
Recurring | Residential mortgage-backed securities | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		15,475
Debt securities available-for-sale	13,670
Recurring | Corporate and other securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		63,000
Debt securities available-for-sale	61,765
Recurring | Corporate and other securities | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		58,325
Debt securities available-for-sale	57,502
Recurring | Corporate and other securities | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt securities available-for-sale		4,675
Debt securities available-for-sale	4,263
Recurring | Interest Rate Swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Swap agreements	1,264	1,537
Recurring | Interest Rate Swap | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Swap agreements	$ 1,264	$ 1,537

Fair Value - Assets and Liabi_2

Fair Value - Assets and Liabilities Subject to Fair Value Adjustments on a Nonrecurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Individually evaluated	$ 1,700
Individually evaluated for impairment		$ 1,779
Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
OREO	251
Collateral-dependent loans	13,738	8,803
Nonrecurring | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
OREO	251
Collateral-dependent loans	$ 13,738	$ 8,803

Fair Value - Carrying Amount an

Fair Value - Carrying Amount and Fair Values (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Financial assets:
Debt securities held to maturity	$ 27,155	$ 28,578
Level 2
Financial assets:
Debt securities held to maturity	27,155	28,578
SBA loans held for sale	20,322	30,141
Loans, net of allowance for loan losses		1,981,207
Financial liabilities:
Deposits	1,871,627	1,772,270
Borrowed funds and subordinated debentures	397,323	391,312
Level 3
Financial assets:
Loans, net of allowance for loan losses	2,027,127	8,803
Carrying amount
Financial assets:
Debt securities held to maturity	35,956	35,760
SBA loans held for sale	19,387	27,928
Loans, net of allowance for loan losses	2,127,885	2,053,435
Financial liabilities:
Deposits	1,884,910	1,787,528
Borrowed funds and subordinated debentures	$ 398,920	$ 393,310

Securities - Amortized Cost to

Securities - Amortized Cost to Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Available for sale:
Available for sale at amortized cost	$ 98,577
Total		$ 101,188
Gross unrealized gains	149	138
Gross unrealized losses	(6,604)	(5,933)
Estimated fair value		95,393
Estimated fair value	92,122
Held to maturity:
Held to maturity, Amortized cost	35,956
Amortized cost		35,760
Gross unrealized gains	5	67
Gross unrealized losses	(8,806)	(7,249)
Estimated fair value	27,155	28,578
U.S. Government sponsored entities
Available for sale:
Available for sale at amortized cost	17,133
Total		16,961
Gross unrealized losses	(808)	(656)
Estimated fair value		16,305
Estimated fair value	16,325
Held to maturity:
Held to maturity, Amortized cost	28,000
Amortized cost		28,000
Gross unrealized losses	(6,096)	(5,310)
Estimated fair value	21,904	22,690
State and political subdivisions
Available for sale:
Available for sale at amortized cost	407
Total		635
Gross unrealized losses	(45)	(22)
Estimated fair value		613
Estimated fair value	362
Held to maturity:
Held to maturity, Amortized cost	1,158
Amortized cost		1,115
Gross unrealized gains	5	67
Gross unrealized losses	(3)
Estimated fair value	1,160	1,182
Residential mortgage-backed securities
Available for sale:
Available for sale at amortized cost	15,835
Total		17,097
Gross unrealized gains	28	32
Gross unrealized losses	(2,193)	(1,654)
Estimated fair value		15,475
Estimated fair value	13,670
Held to maturity:
Held to maturity, Amortized cost	6,798
Amortized cost		6,645
Gross unrealized losses	(2,707)	(1,939)
Estimated fair value	4,091	4,706
Corporate and other securities
Available for sale:
Available for sale at amortized cost	65,202
Total		66,495
Gross unrealized gains	121	106
Gross unrealized losses	(3,558)	(3,601)
Estimated fair value		$ 63,000
Estimated fair value	$ 61,765

Securities - Securities By Cont

Securities - Securities By Contractual Maturity (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Available for sale at amortized cost
Due in one year	$ 2,133
Due after one year through five years	30,779
Due after five years through ten years	10,984
Due after ten years	38,846
Available for sale at amortized cost	98,577
Available for sale at fair value
Due in one year	2,114
Due after one year through five years	29,404
Due after five years through ten years	9,616
Due after ten years	37,318
Available of sale at fair value	92,122
Held to maturity at amortized cost
Due after five years through ten years	3,000
Due after ten years	26,158
Held to maturity, Amortized cost	35,956
Held to maturity at fair value
Due after five years through ten years	2,819
Due after ten years	20,245
Held to maturity, Fair Value	27,155	$ 28,578
Residential mortgage-backed securities
Available for sale at amortized cost
Residential mortgage-backed securities	15,835
Available for sale at amortized cost	15,835
Available for sale at fair value
Residential mortgage-backed securities	13,670
Available of sale at fair value	13,670
Held to maturity at amortized cost
Residential mortgage-backed securities	6,798
Held to maturity, Amortized cost	6,798
Held to maturity at fair value
Residential mortgage-backed securities	4,091
Held to maturity, Fair Value	$ 4,091	$ 4,706

Securities - Securities in Unre

Securities - Securities in Unrealized Loss Position (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Available for sale:
Available for sale, Less than 12 months, Estimated fair value	$ 6,887	$ 53,445
Available for sale, Less than 12 months, Unrealized loss	(330)	(3,041)
Available for sale, 12 months and greater, Estimated fair value	82,568	34,944
Available for sale, 12 Months and greater Unrealized loss	(6,274)	(2,892)
Available for sale, Estimated fair value	89,455	88,389
Available for sale, Unrealized loss	(6,604)	(5,933)
Held to maturity:
Held to maturity, Less than 12 months Estimated fair value	571	20,366
Held to maturity, Less than 12 months Unrealized loss	(3)	(4,280)
Held to maturity, 12 months and greater, Estimated fair value	25,995	7,031
Held to maturity, 12 months and greater, Unrealized loss	(8,803)	(2,969)
Held to maturity, Total Estimated fair value	26,566	27,397
Held to maturity, Total Unrealized loss	(8,806)	(7,249)
U.S. Government sponsored entities
Available for sale:
Available for sale, Less than 12 months, Estimated fair value	2,114	15,817
Available for sale, Less than 12 months, Unrealized loss	(19)	(622)
Available for sale, 12 months and greater, Estimated fair value	14,211	1,432
Available for sale, 12 Months and greater Unrealized loss	(789)	(34)
Available for sale, Estimated fair value	16,325	17,249
Available for sale, Unrealized loss	(808)	(656)
Held to maturity:
Held to maturity, Less than 12 months Estimated fair value		15,659
Held to maturity, Less than 12 months Unrealized loss		(2,341)
Held to maturity, 12 months and greater, Estimated fair value	21,904	7,031
Held to maturity, 12 months and greater, Unrealized loss	(6,096)	(2,969)
Held to maturity, Total Estimated fair value	21,904	22,690
Held to maturity, Total Unrealized loss	(6,096)	(5,310)
State and political subdivisions
Available for sale:
Available for sale, Less than 12 months, Estimated fair value		160
Available for sale, Less than 12 months, Unrealized loss		(5)
Available for sale, 12 months and greater, Estimated fair value	362	253
Available for sale, 12 Months and greater Unrealized loss	(45)	(17)
Available for sale, Estimated fair value	362	413
Available for sale, Unrealized loss	(45)	(22)
Held to maturity:
Held to maturity, Less than 12 months Estimated fair value	571
Held to maturity, Less than 12 months Unrealized loss	(3)
Held to maturity, Total Estimated fair value	571
Held to maturity, Total Unrealized loss	(3)
Residential mortgage-backed securities
Available for sale:
Available for sale, Less than 12 months, Estimated fair value	81	14,023
Available for sale, Less than 12 months, Unrealized loss	(3)	(1,448)
Available for sale, 12 months and greater, Estimated fair value	13,543	1,311
Available for sale, 12 Months and greater Unrealized loss	(2,190)	(206)
Available for sale, Estimated fair value	13,624	15,334
Available for sale, Unrealized loss	(2,193)	(1,654)
Held to maturity:
Held to maturity, Less than 12 months Estimated fair value		4,707
Held to maturity, Less than 12 months Unrealized loss		(1,939)
Held to maturity, 12 months and greater, Estimated fair value	4,091
Held to maturity, 12 months and greater, Unrealized loss	(2,707)
Held to maturity, Total Estimated fair value	4,091	4,707
Held to maturity, Total Unrealized loss	(2,707)	(1,939)
Corporate and other securities
Available for sale:
Available for sale, Less than 12 months, Estimated fair value	4,692	23,445
Available for sale, Less than 12 months, Unrealized loss	(308)	(966)
Available for sale, 12 months and greater, Estimated fair value	54,452	31,948
Available for sale, 12 Months and greater Unrealized loss	(3,250)	(2,635)
Available for sale, Estimated fair value	59,144	55,393
Available for sale, Unrealized loss	$ (3,558)	$ (3,601)

Securities - Realized Gains (Lo

Securities - Realized Gains (Losses) on Debt Securities (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Available for sale:
Impairment for available for sale	$ 0	$ 0	$ 0	$ 0
Allowance for credit losses for available for sale	0	0	0	0
Realized gains or losses	0	0	0	0
Held to maturity:
Realized gains	0	0	0	0
Realized losses	0	0	0	0
Impairment for held to maturity	0	0	0	0
Allowance for credit losses for held to maturity	$ 0	$ 0	$ 0	$ 0

Securities - Realized Gains (_2

Securities - Realized Gains (Losses) for Equity Securities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Securities
Net unrealized losses occurring during the period on equity securities	$ (144)	$ (576)	$ (853)	$ (1,631)
Net realized gains recognized during the period on equity securities sold during the period	21		243
Net losses recognized during the reporting period on equity securities still held at the reporting date	$ (123)	$ (576)	$ (610)	$ (1,631)

Loans - Classification of Loans

Loans - Classification of Loans By Class (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		$ 2,106,559
Total Loans	$ 2,173,190
SBA 504 loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		35,077
Total Loans	31,808
SBA loans held for investment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		38,468
Total Loans	40,873
SBA PPP loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		5,908
Total Loans	2,507
Commercial loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		1,187,543
Total Loans	1,276,156
Commercial loans | SBA 504 loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		35,077
Commercial loans | Commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		903,126
Total Loans	968,801
Commercial loans | Commercial real estate construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		131,774
Total Loans	144,580
Commercial loans | Consumer other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		117,566
Total Loans	130,967
Residential mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		605,091
Total Loans	628,628
Consumer loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		78,164
Total Loans	72,189
Consumer loans | Home equity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		68,310
Total Loans	65,461
Consumer loans | Consumer other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		9,854
Total Loans	6,728
Residential construction loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		163,457
Total Loans	133,450
Total loans held for investment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		2,078,631
Total Loans	2,153,803
SBA loans held for sale
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans		$ 27,928
Total Loans	$ 19,387

Loans - Narrative (Details)

Loans - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Prepaid expenses and other assets	$ 22,442	$ 14,740
Residential loans in process of foreclosure	$ 12,500	2,100
Financing Receivable, Practical Expedient, Accrued Interest Exclusion [true false]	true
Accrued interest on securities	$ 1,500
Accrued interest on loans	$ 14,100
Maximum
Guarantee percentage of SBA Loan	90%
Commercial properties
Prepaid expenses and other assets	$ 300	$ 0

Loans - Aging Analysis of Past

Loans - Aging Analysis of Past Due and Nonaccrual Loans by Class (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Financing Receivable, Recorded Investment [Line Items]
Total loans		$ 2,106,559
Total loans	$ 2,173,190
SBA 504 loans
Financing Receivable, Recorded Investment [Line Items]
Total loans		35,077
Total loans	31,808
SBA loans held for investment
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	40,873	38,468
Total loans		38,468
Total loans	40,873
SBA loans held for investment | 30-59 days past due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	4,083
SBA loans held for investment | 60-89 days past due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	420	576
SBA loans held for investment | Nonaccrual
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	3,445	690
SBA loans held for investment | Past Due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	7,948	1,266
SBA loans held for investment | Current
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	32,925	37,202
SBA PPP loans
Financing Receivable, Recorded Investment [Line Items]
Total loans		5,908
Total loans	2,507
Commercial loans
Financing Receivable, Recorded Investment [Line Items]
Total loans		1,187,543
Total loans	1,276,156
Commercial loans | SBA 504 loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	31,808	35,077
Total loans		35,077
Commercial loans | Commercial real estate
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	968,801	903,126
Total loans		903,126
Total loans	968,801
Commercial loans | Commercial real estate construction
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	144,580	131,774
Total loans		131,774
Total loans	144,580
Commercial loans | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	130,967	117,566
Total loans		117,566
Total loans	130,967
Commercial loans | 30-59 days past due | Commercial real estate
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	553	22
Commercial loans | 30-59 days past due | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP		198
Commercial loans | 60-89 days past due | Commercial real estate
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP		188
Commercial loans | 60-89 days past due | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP		300
Commercial loans | Nonaccrual | Commercial real estate
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	82	805
Commercial loans | Nonaccrual | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	668	777
Commercial loans | Past Due | Commercial real estate
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	635	1,015
Commercial loans | Past Due | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	668	1,275
Commercial loans | Current | SBA 504 loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	31,808	35,077
Commercial loans | Current | Commercial real estate
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	968,166	902,111
Commercial loans | Current | Commercial real estate construction
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	144,580	131,774
Commercial loans | Current | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	130,299	116,291
Residential mortgage loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	628,628	605,091
Total loans		605,091
Total loans	628,628
Residential mortgage loans | 30-59 days past due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	4,961
Residential mortgage loans | 60-89 days past due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	3,347	982
Residential mortgage loans | 90 days and still accruing
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	260
Residential mortgage loans | Nonaccrual
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	10,270	3,361
Residential mortgage loans | Past Due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	18,838	4,343
Residential mortgage loans | Current
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	609,790	600,748
Consumer loans
Financing Receivable, Recorded Investment [Line Items]
Total loans		78,164
Total loans	72,189
Consumer loans | Home equity
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	65,461	68,310
Total loans		68,310
Total loans	65,461
Consumer loans | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	6,728	9,854
Total loans		9,854
Total loans	6,728
Consumer loans | 30-59 days past due | Home equity
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	286
Consumer loans | 30-59 days past due | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	1,319	18
Consumer loans | 60-89 days past due | Home equity
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	15
Consumer loans | 60-89 days past due | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	52	7
Consumer loans | 90 days and still accruing | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	5
Consumer loans | Nonaccrual | Home equity
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	125
Consumer loans | Past Due | Home equity
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	426
Consumer loans | Past Due | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	1,376	25
Consumer loans | Current | Home equity
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	65,035	68,310
Consumer loans | Current | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	5,352	9,829
Residential construction loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	133,450	163,457
Total loans		163,457
Total loans	133,450
Residential construction loans | Nonaccrual
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	3,201	3,432
Residential construction loans | Past Due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	3,201	3,432
Residential construction loans | Current
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	130,249	160,025
Residential mortgage, consumer and residential construction loans
Financing Receivable, Recorded Investment [Line Items]
Total loans		846,712
Total loans held for investment including PPP
Financing Receivable, Recorded Investment [Line Items]
Total loans		2,078,631
Total loans	2,153,803
Total loans held for investment excluding SBA PPP
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	2,151,296	2,072,723
Total loans	2,151,296
Total loans held for investment excluding SBA PPP | 30-59 days past due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	11,202	238
Total loans held for investment excluding SBA PPP | 60-89 days past due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	3,834	2,053
Total loans held for investment excluding SBA PPP | 90 days and still accruing
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	265
Total loans held for investment excluding SBA PPP | Nonaccrual
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	17,791	9,065
Total loans held for investment excluding SBA PPP | Past Due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	33,092	11,356
Total loans held for investment excluding SBA PPP | Current
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	2,118,204	2,061,367
SBA loans held for sale
Financing Receivable, Recorded Investment [Line Items]
Total loans		27,928
Total loans	19,387
SBA loans held for sale | 30-59 days past due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	815	2,195
SBA loans held for sale | Past Due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	815	2,195
SBA loans held for sale | Current
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	18,572	25,733
Total loans excluding SBA PPP loans
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	2,170,683	2,100,651
Total loans excluding SBA PPP loans | 30-59 days past due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	12,017	2,433
Total loans excluding SBA PPP loans | 60-89 days past due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	3,834	2,053
Total loans excluding SBA PPP loans | 90 days and still accruing
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	265
Total loans excluding SBA PPP loans | Nonaccrual
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	17,791	9,065
Total loans excluding SBA PPP loans | Past Due
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	33,907	13,551
Total loans excluding SBA PPP loans | Current
Financing Receivable, Recorded Investment [Line Items]
Total loans, excluding SBA PPP	$ 2,136,776	$ 2,087,100

Loans - Risk by loan portfolio

Loans - Risk by loan portfolio (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Dec. 31, 2022
Financing Receivable, Recorded Investment [Line Items]
Total loans			$ 2,106,559
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
Total Loans	$ 2,173,190	$ 2,173,190
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss, Writeoff, by Origination Year [Abstract]
Total loans	652	2,010
SBA 504 loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			35,077
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
Total Loans	31,808	31,808
SBA loans held for investment
Financing Receivable, Recorded Investment [Line Items]
Total loans			38,468
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2023	1,057	1,057
2022	10,166	10,166
2021	7,376	7,376
2020	6,831	6,831
2019	2,669	2,669
2018 and Earlier	12,774	12,774
Total Loans	40,873	40,873
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss, Writeoff, by Origination Year [Abstract]
2022		100
2019		113
Total loans	100	213
SBA and commercial loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			1,231,919
SBA PPP loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			5,908
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2021	2,507	2,507
Total Loans	2,507	2,507
Commercial loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			1,187,543
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2023	101,748	101,748
2022	358,496	358,496
2021	187,142	187,142
2020	137,086	137,086
2019	104,039	104,039
2018 and Earlier	291,628	291,628
Revolving Loans Amortized Cost Basis	96,017	96,017
Total Loans	1,276,156	1,276,156
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss, Writeoff, by Origination Year [Abstract]
2021		150
2019		350
Total loans	500	500
Commercial loans | SBA 504 loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			35,077
Commercial loans | Commercial real estate
Financing Receivable, Recorded Investment [Line Items]
Total loans			903,126
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
Total Loans	968,801	968,801
Commercial loans | Commercial real estate construction
Financing Receivable, Recorded Investment [Line Items]
Total loans			131,774
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
Total Loans	144,580	144,580
Commercial loans | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans			117,566
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
Total Loans	130,967	130,967
Residential mortgage loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			605,091
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2023	88,707	88,707
2022	261,604	261,604
2021	74,511	74,511
2020	53,487	53,487
2019	33,220	33,220
2018 and Earlier	117,099	117,099
Total Loans	628,628	628,628
Consumer loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			78,164
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2023	3,041	3,041
2022	5,103	5,103
2021	4,450	4,450
2020	696	696
2019	2,589	2,589
2018 and Earlier	8,045	8,045
Revolving Loans Amortized Cost Basis	48,265	48,265
Total Loans	72,189	72,189
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss, Writeoff, by Origination Year [Abstract]
2021		397
Total loans	52	397
Consumer loans | Home equity
Financing Receivable, Recorded Investment [Line Items]
Total loans			68,310
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
Total Loans	65,461	65,461
Consumer loans | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans			9,854
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
Total Loans	6,728	6,728
Residential construction loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			163,457
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2023	20,697	20,697
2022	72,544	72,544
2021	34,542	34,542
2020	2,097	2,097
2019	500	500
2018 and Earlier	2,035	2,035
Revolving Loans Amortized Cost Basis	1,035	1,035
Total Loans	133,450	133,450
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss, Writeoff, by Origination Year [Abstract]
2018 and Earlier		500
Revolving Loans Amortized Cost Basis		400
Total loans		900
Total loans held for investment including PPP
Financing Receivable, Recorded Investment [Line Items]
Total loans			2,078,631
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2023	215,250	215,250
2022	707,913	707,913
2021	310,528	310,528
2020	200,197	200,197
2019	143,017	143,017
2018 and Earlier	431,581	431,581
Revolving Loans Amortized Cost Basis	145,317	145,317
Total Loans	2,153,803	2,153,803
Residential mortgage, consumer and residential construction loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			846,712
Performing | Residential mortgage loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			601,730
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2023	83,675	83,675
2022	259,430	259,430
2021	73,961	73,961
2020	52,432	52,432
2019	32,944	32,944
2018 and Earlier	115,498	115,498
Total Loans	617,940	617,940
Performing | Consumer loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			78,164
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2023	3,041	3,041
2022	5,103	5,103
2021	4,450	4,450
2020	696	696
2019	2,589	2,589
2018 and Earlier	8,045	8,045
Revolving Loans Amortized Cost Basis	47,875	47,875
Total Loans	71,799	71,799
Performing | Consumer loans | Home equity
Financing Receivable, Recorded Investment [Line Items]
Total loans			68,310
Performing | Consumer loans | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans			9,854
Performing | Residential construction loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			160,025
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2023	20,697	20,697
2022	72,544	72,544
2021	34,165	34,165
2020	1,550	1,550
2019	500	500
2018 and Earlier	732	732
Total Loans	130,188	130,188
Performing | Residential mortgage, consumer and residential construction loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			839,919
Nonperforming | Residential mortgage loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			3,361
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2023	5,032	5,032
2022	2,174	2,174
2021	550	550
2020	1,055	1,055
2019	276	276
2018 and Earlier	1,601	1,601
Total Loans	10,688	10,688
Nonperforming | Consumer loans
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
Revolving Loans Amortized Cost Basis	390	390
Total Loans	390	390
Nonperforming | Residential construction loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			3,432
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2021	377	377
2020	547	547
2018 and Earlier	1,303	1,303
Revolving Loans Amortized Cost Basis	1,035	1,035
Total Loans	3,262	3,262
Nonperforming | Residential mortgage, consumer and residential construction loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			6,793
Pass | SBA loans held for investment
Financing Receivable, Recorded Investment [Line Items]
Total loans			37,163
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2023	1,057	1,057
2022	7,113	7,113
2021	5,151	5,151
2020	6,131	6,131
2019	2,669	2,669
2018 and Earlier	11,334	11,334
Total Loans	33,455	33,455
Pass | SBA and commercial loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			1,214,139
Pass | SBA PPP loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			5,908
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2021	2,507	2,507
Total Loans	2,507	2,507
Pass | Commercial loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			1,171,068
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2023	101,748	101,748
2022	358,414	358,414
2021	186,930	186,930
2020	136,850	136,850
2019	102,312	102,312
2018 and Earlier	278,861	278,861
Revolving Loans Amortized Cost Basis	95,372	95,372
Total Loans	1,260,487	1,260,487
Pass | Commercial loans | SBA 504 loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			35,077
Pass | Commercial loans | Commercial real estate
Financing Receivable, Recorded Investment [Line Items]
Total loans			894,110
Pass | Commercial loans | Commercial real estate construction
Financing Receivable, Recorded Investment [Line Items]
Total loans			131,774
Pass | Commercial loans | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans			110,107
Special mention | SBA loans held for investment
Financing Receivable, Recorded Investment [Line Items]
Total loans			558
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2022	1,797	1,797
2020	510	510
2018 and Earlier	778	778
Total Loans	3,085	3,085
Special mention | SBA and commercial loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			13,006
Special mention | Commercial loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			12,448
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2022	82	82
2021	212	212
2019	1,727	1,727
2018 and Earlier	10,307	10,307
Revolving Loans Amortized Cost Basis	645	645
Total Loans	12,973	12,973
Special mention | Commercial loans | Commercial real estate
Financing Receivable, Recorded Investment [Line Items]
Total loans			6,228
Special mention | Commercial loans | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans			6,220
Substandard | SBA loans held for investment
Financing Receivable, Recorded Investment [Line Items]
Total loans			747
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2022	1,256	1,256
2021	2,225	2,225
2020	190	190
2018 and Earlier	662	662
Total Loans	4,333	4,333
Substandard | SBA and commercial loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			4,774
Substandard | Commercial loans
Financing Receivable, Recorded Investment [Line Items]
Total loans			4,027
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]
2020	236	236
2018 and Earlier	2,460	2,460
Total Loans	$ 2,696	$ 2,696
Substandard | Commercial loans | Commercial real estate
Financing Receivable, Recorded Investment [Line Items]
Total loans			2,788
Substandard | Commercial loans | Consumer other
Financing Receivable, Recorded Investment [Line Items]
Total loans			$ 1,239

Loans - Disaggregated by class

Loans - Disaggregated by class of gross loans and type of concession granted (Details) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2023 USD ($)
Financing Receivable, Recorded Investment [Line Items]
Loans	$ 0	$ 0
Commercial loans
Financing Receivable, Recorded Investment [Line Items]
Amortized Cost Basis	952	$ 952
Total Class of Gross Loans		0.10%
Weighted Average of years		7 years 8 months 12 days
SBA
Financing Receivable, Recorded Investment [Line Items]
Amortized Cost Basis	$ 9	$ 9
Total Class of Gross Loans		0%

Allowance for Credit Losses a_3

Allowance for Credit Losses and Reserve for Unfunded Loan Commitments - Activity in the Allowance for Loan Losses by Portfolio Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]
Charge-offs	$ (652)		$ (2,010)
Recoveries	48		466
Net recoveries (charge-offs)	(604)		(1,544)
Provision for loan losses charged to expense	534		1,419
Balance, end of period	25,918		25,918
Allowance for Loan and Lease Losses [Roll Forward]
Balance, beginning of period	25,988	$ 22,858	25,196	$ 22,302
Charge-offs		(551)		(1,097)
Recoveries		37		130
Net recoveries (charge-offs)		(514)		(967)
Provision for (credit to) loan losses charged to expense		1,517		2,526
Balance, end of period		23,861		23,861
Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]
Balance, end of period	847		847
SBA loans held for investment
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]
Charge-offs	(100)		(213)
Recoveries	1		16
Net recoveries (charge-offs)	(99)		(197)
Provision for loan losses charged to expense	199		815
Balance, end of period	1,656		1,656
Allowance for Loan and Lease Losses [Roll Forward]
Balance, beginning of period	1,556		875
SBA loans held for investment | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]
Balance, end of period	163		163
Total SBA loans
Allowance for Loan and Lease Losses [Roll Forward]
Balance, beginning of period		758	875	1,074
Recoveries		5		33
Net recoveries (charge-offs)		5		33
Provision for (credit to) loan losses charged to expense		68		(276)
Balance, end of period		831		831
Commercial loans
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]
Charge-offs	(500)		(500)
Recoveries	10		377
Net recoveries (charge-offs)	(490)		(123)
Provision for loan losses charged to expense	325
(Credit to) loan losses charged to expense			(49)
Balance, end of period	15,351		15,351
Allowance for Loan and Lease Losses [Roll Forward]
Balance, beginning of period	15,516	14,908	15,254	15,053
Charge-offs		(501)		(1,001)
Recoveries		23		83
Net recoveries (charge-offs)		(478)		(918)
Provision for (credit to) loan losses charged to expense		803		1,098
Balance, end of period		15,233		15,233
Commercial loans | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]
Balance, end of period	171		171
Residential mortgage loans
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]
Provision for loan losses charged to expense	6		605
Balance, end of period	6,431		6,431
Allowance for Loan and Lease Losses [Roll Forward]
Balance, beginning of period	6,437	4,786	5,450	4,114
Recoveries				1
Net recoveries (charge-offs)				1
Provision for (credit to) loan losses charged to expense		449		1,120
Balance, end of period		5,235		5,235
Residential mortgage loans | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]
Balance, end of period	376		376
Consumer loans
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]
Charge-offs	(52)		(397)
Recoveries	37		73
Net recoveries (charge-offs)	(15)		(324)
Provision for loan losses charged to expense	130		193
Balance, end of period	960		960
Allowance for Loan and Lease Losses [Roll Forward]
Balance, beginning of period	845	803	990	671
Charge-offs		(50)		(96)
Recoveries		9		13
Net recoveries (charge-offs)		(41)		(83)
Provision for (credit to) loan losses charged to expense		349		523
Balance, end of period		1,111		1,111
Consumer loans | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]
Balance, end of period	101		101
Residential construction loans
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]
Charge-offs			(900)
Net recoveries (charge-offs)			(900)
(Credit to) loan losses charged to expense	(114)		(243)
Balance, end of period	1,520		1,520
Allowance for Loan and Lease Losses [Roll Forward]
Balance, beginning of period	1,634	1,603	2,627	1,390
Provision for (credit to) loan losses charged to expense		(152)		61
Balance, end of period		$ 1,451		$ 1,451
Residential construction loans | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]
Balance, end of period	$ 36		$ 36

Allowance for Credit Losses a_4

Allowance for Credit Losses and Reserve for Unfunded Loan Commitments - Allowance for Credit Losses on Basis of Impairment Method (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021
Financing Receivable, Allowance for Credit Losses [Line Items]
Individually evaluated for impairment			$ 1,779
Collectively evaluated for impairment			23,417
Individually evaluated	$ 1,700
Total		$ 25,988	25,196	$ 23,861	$ 22,858	$ 22,302
Total	25,918
Individually evaluated for impairment			10,584
Collectively evaluated for impairment			2,095,975
Total loans			2,106,559
Total Loans	2,173,190
SBA loans held for investment
Financing Receivable, Allowance for Credit Losses [Line Items]
Individually evaluated	619
Collectively evaluated	1,037
Total		1,556	875
Total	1,656
Individually evaluated for impairment	256
Collectively evaluated for impairment	40,617
Total loans			38,468
Total Loans	40,873
Total SBA loans
Financing Receivable, Allowance for Credit Losses [Line Items]
Individually evaluated for impairment			115
Collectively evaluated for impairment			760
Total			875	831	758	1,074
Individually evaluated for impairment			690
Collectively evaluated for impairment			71,614
Total loans			72,304
Commercial loans
Financing Receivable, Allowance for Credit Losses [Line Items]
Individually evaluated for impairment			516
Collectively evaluated for impairment			14,738
Individually evaluated	369
Collectively evaluated	14,982
Total		15,516	15,254	15,233	14,908	15,053
Total	15,351
Individually evaluated for impairment	750
Individually evaluated for impairment			3,101
Collectively evaluated for impairment	1,275,406
Collectively evaluated for impairment			1,184,442
Total loans			1,187,543
Total Loans	1,276,156
Residential mortgage loans
Financing Receivable, Allowance for Credit Losses [Line Items]
Individually evaluated for impairment			36
Collectively evaluated for impairment			5,414
Individually evaluated	386
Collectively evaluated	6,045
Total		6,437	5,450	5,235	4,786	4,114
Total	6,431
Individually evaluated for impairment	11,059
Individually evaluated for impairment			3,361
Collectively evaluated for impairment	617,569
Collectively evaluated for impairment			601,730
Total loans			605,091
Total Loans	628,628
Consumer loans
Financing Receivable, Allowance for Credit Losses [Line Items]
Collectively evaluated for impairment			990
Collectively evaluated	960
Total		845	990	1,111	803	671
Total	960
Individually evaluated for impairment	131
Collectively evaluated for impairment	72,058
Collectively evaluated for impairment			78,164
Total loans			78,164
Total Loans	72,189
Residential construction loans
Financing Receivable, Allowance for Credit Losses [Line Items]
Individually evaluated for impairment			1,112
Collectively evaluated for impairment			1,515
Individually evaluated	285
Collectively evaluated	1,235
Total		$ 1,634	2,627	$ 1,451	$ 1,603	$ 1,390
Total	1,520
Individually evaluated for impairment	3,201
Individually evaluated for impairment			3,432
Collectively evaluated for impairment	130,249
Collectively evaluated for impairment			160,025
Total loans			163,457
Total Loans	133,450
Total loans held for investment including PPP
Financing Receivable, Allowance for Credit Losses [Line Items]
Total loans			$ 2,078,631
Total Loans	2,153,803
Total loans held for investment excluding SBA PPP
Financing Receivable, Allowance for Credit Losses [Line Items]
Individually evaluated	1,659
Collectively evaluated	24,259
Total	25,918
Individually evaluated for impairment	15,397
Collectively evaluated for impairment	2,135,899
Total Loans	$ 2,151,296

Allowance for Credit Losses a_5

Allowance for Credit Losses and Reserve for Unfunded Loan Commitments - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2023
Financing Receivable, Allowance for Credit Losses [Line Items]
Provision for unfunded loan commitments reserves	$ 1,517	$ 2,526
Unfunded loan commitment
Financing Receivable, Allowance for Credit Losses [Line Items]
Reserve for commitments			$ 500

Derivative Financial Instrume_3

Derivative Financial Instruments and Hedging Activities (Details) - Interest Rate Swap - Designated as hedging instrument $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023 USD ($) contract	Dec. 31, 2022 USD ($) contract
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 20,000	$ 20,000
Fair value	$ 1,264	$ 1,537
Weighted average pay rate	0.83%	0.83%
Weighted average receive rate	5.56%	1.50%
Weighted average maturity in years	1 year 5 months 8 days	2 years 6 months 25 days
Number of contracts | contract	1	1

Derivative Financial Instrume_4

Derivative Financial Instruments and Hedging Activities - Gain (Loss) in AOCI (Details) - AOCI (loss) gain on cash flow derivative instruments - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosures [Line Items]
(Loss) Gain recognized in OCI	$ (139)	$ 452	$ (273)	$ 1,386
Gain reclassified from AOCI into net income	$ 238		$ 656

Employee Benefit Plans - Narrat

Employee Benefit Plans - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	May 05, 2023
Share-based Compensation Arrangement by Share-based Payment Award
Options granted (in shares)	0	0
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting period	3 years
Award expiration period	10 years
Compensation cost not yet recognized	$ 104
Compensation cost recognition weighted average period	4 months 24 days
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Award vesting period	4 years
Compensation cost recognition weighted average period	2 years 8 months 12 days
Nonvested awards, compensation not yet recognized, awards other than options	$ 3,500
2023 Equity Compensation Plan
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares authorized (in shares)			500,000
Number of shares available for grant (in shares)	484,427
2023 Equity Compensation Plan | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Options granted (in shares)	281,500
Unvested options cancelled and returned	16,828
2023 Equity Compensation Plan | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Options granted (in shares)	267,900
Unvested options cancelled and returned	16,999

Employee Benefit Plans - Stock

Employee Benefit Plans - Stock Transactions - Stock Option Plans (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Shares
Options Outstanding, beginning shares (in shares)			559,499
Options granted (in shares)			0	0
Options exercised (in shares)	(22,249)	(23,168)	(73,184)	(85,877)
Options forfeited, shares			(1,332)
Options Outstanding, ending shares (in shares)	484,983		484,983		559,499
Shares Exercisable	445,825		445,825
Weighted average exercise price
Weighted Average exercise Price: Options Outstanding, beginning (in usd per share)			$ 18.09
Weighted Average Exercise Price: Options exercised (in usd per share)			19.04
Weighted Average Exercise Price: Options forfeited (in usd per share)			18.64
Weighted Average exercise Price: Options Outstanding, ending (in usd per share)	$ 17.95		17.95		$ 18.09
Weighted average exercise price, Options Exercisable (in dollars per share)	$ 17.85		$ 17.85
Weighted Average Remaining Contractual Life (in years): Options Outstanding			5 years 2 months 12 days		5 years 10 months 24 days
Weighted Average Remaining Contractual Life (in years): Options Exercisable			5 years
Aggregate Intrinsic Value: Options Outstanding	$ 2,659,163		$ 2,659,163		$ 5,168,740
Aggregate Intrinsic Value: Options Exercisable	$ 2,488,426		$ 2,488,426

Employee Benefit Plans - Schedu

Employee Benefit Plans - Schedule of Information About Options Exercised (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Employee Benefit Plans
Number of options exercised	22,249	23,168	73,184	85,877
Total intrinsic value of options exercised	$ 164,978	$ 215,476	$ 480,981	$ 1,081,833
Cash received from options exercised	394,665	441,272	1,393,551	1,394,809
Tax deduction realized from options	$ 49,634	$ 64,826	$ 144,703	$ 325,469

Employee Benefit Plans - Stoc_2

Employee Benefit Plans - Stock Transactions - Stock Options Outstanding And Exercisable (Details)	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range
Options outstanding (in shares) | shares	484,983
Options outstanding, Weighted average remaining contractual life (in years)	5 years 2 months 12 days
Options outstanding, Weighted average exercise price (in dollars per share)	$ 17.95
Options exercisable (in shares) | shares	445,825
Options exercisable, Weighted average exercise price (in dollars per share)	$ 17.85
$7.25 - $16.51
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range
Range of exercise prices, lower	7.25
Range of exercise prices, upper	$ 16.51
Options outstanding (in shares) | shares	128,873
Options outstanding, Weighted average remaining contractual life (in years)	3 years 4 months 24 days
Options outstanding, Weighted average exercise price (in dollars per share)	$ 12.01
Options exercisable (in shares) | shares	128,873
Options exercisable, Weighted average exercise price (in dollars per share)	$ 12.01
$16.52 - $19.26
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range
Range of exercise prices, lower	16.52
Range of exercise prices, upper	$ 19.26
Options outstanding (in shares) | shares	120,499
Options outstanding, Weighted average remaining contractual life (in years)	6 years
Options outstanding, Weighted average exercise price (in dollars per share)	$ 18.03
Options exercisable (in shares) | shares	97,674
Options exercisable, Weighted average exercise price (in dollars per share)	$ 18.04
$19.27 - $20.88
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range
Range of exercise prices, lower	19.27
Range of exercise prices, upper	$ 20.88
Options outstanding (in shares) | shares	127,411
Options outstanding, Weighted average remaining contractual life (in years)	5 years 10 months 24 days
Options outstanding, Weighted average exercise price (in dollars per share)	$ 20.33
Options exercisable (in shares) | shares	111,078
Options exercisable, Weighted average exercise price (in dollars per share)	$ 20.30
$20.89 - $22.57
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range
Range of exercise prices, lower	20.89
Range of exercise prices, upper	$ 22.57
Options outstanding (in shares) | shares	108,200
Options outstanding, Weighted average remaining contractual life (in years)	5 years 9 months 18 days
Options outstanding, Weighted average exercise price (in dollars per share)	$ 22.11
Options exercisable (in shares) | shares	108,200
Options exercisable, Weighted average exercise price (in dollars per share)	$ 22.11

Employee Benefit Plans - Compen

Employee Benefit Plans - Compensation Expense Related To Stock Options (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Compensation expense	$ 72	$ 129	$ 236	$ 431
Income tax benefit	21	37	68	125
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Compensation expense	357	276	1,033	808
Income tax benefit	$ 103	$ 80	$ 298	$ 234

Employee Benefit Plans - Restri

Employee Benefit Plans - Restricted Stock Activity (Details) - Restricted Stock - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Shares
Nonvested restricted stock, beginning balance (in shares)			164,570
Granted (in shares)	3,000	2,000	58,500	73,000
Cancelled (in shares)			(4,599)
Vested (in shares)			(41,973)
Nonvested restricted stock, ending balance (in shares)	176,498		176,498
Average grant date fair value
Nonvested restricted stock, beginning balance (in dollars per share)			$ 24.77
Granted (in dollars per share)	$ 25.24	$ 27.89	22.93	$ 27.54
Cancelled (in dollars per share)			26.37
Vested (in dollars per share)			23.13
Nonvested restricted stock, ending balance (in dollars per share)	$ 24.51		$ 24.51

Employee Benefit Plans - Stoc_3

Employee Benefit Plans - Stock Transactions - Restricted Stock Awards (Details) - Restricted Stock - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares granted (in shares)	3,000	2,000	58,500	73,000
Average grant date fair value (in usd per share)	$ 25.24	$ 27.89	$ 22.93	$ 27.54

Regulatory Capital (Details)

Regulatory Capital (Details)	Sep. 30, 2023	Dec. 31, 2022
Compliance with Regulatory Capital Requirements under Banking Regulations
Leverage ratio	0.1076	0.1088
Bank
Compliance with Regulatory Capital Requirements under Banking Regulations
Leverage ratio	0.1035	0.1034